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Abstract 
 
Clathrin adaptor protein complexes 1 and 2 (AP1 and AP2) have essential functions 
in synaptic vesicle (SV) recycling. In all cell types and tissues, AP1 mediates 
TGN/endosome protein sorting via clathrin-coated-vesicles (CCV), whereas AP2 
transports proteins by clathrin-mediated endocytosis (CME). Both AP complexes 
are heterotetrameric, made of four adaptins. Neurons express the ubiquitous 
AP1/σ1A complex and in addition, the tissue-specific AP1/σ1B complex. In our 
lab, we have generated σ1B-/- mice. The deficiency of σ1B adaptin leads to severe 
learning, memory and motor coordination deficits in the knockout mice. σ1B 
knockout mice are also a model for a severe X-linked mental retardation disease in 
humans, where the σ1B gene has a premature STOP codon. Synapses lacking the 
AP1/σ1B complex, display two major phenotypes. Firstly, synaptic vesicle (SV) 
recycling is impaired, and early endosomes accumulate. The ubiquitous AP1/σ1A 
complex binds to these endosomes and stimulates their maturation into late, multi-
vesicular-body endosomes, up regulating endolysosomal protein transport. 
Secondly, the endocytic AP2 CCV accumulate, a surprise given the reduction in the 
major vesicular transport route, SV recycling. This indicated that CME is a major 
mechanism of synaptic plasticity. AP2 CCV accumulation could be caused by up-
regulation of CME or by the stabilization of AP2 CCV extending their half-life.  
In this project, I have biochemically characterized these AP2 CCV and 
demonstrated that two populations of AP2 CCV exist in synapses. One formed by 
canonical clathrin-mediated-endocytosis (CME) and the other one formed by a 
specialized pathway, which is characterized by a stabilized CCV coat. Both CME 
routes are upregulated two-fold in AP1/σ1B deficient synapses. In addition, the 
longer-lived AP2 CCV of the AP1/σ1B-/- synapses are stabilized by three distinct 
molecular mechanisms compared to the respective AP2 CCV from wt synapses. 
The stabilized AP2 CCV of AP1/σ1B-/- synapses are enriched in the active zone 
proteins, Stonin2 and Git1. The AP1/σ1B deficient synapses contain more Git1 than 
wild-type synapses, indicating alterations in the dynamics of the active zone in these 
synapses. Thus, two CME routes characterized by specific lifetimes and specific 
cargo proteins contribute to synaptic plasticity. 
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Chapter 1: Introduction 
 
1.1 Intracellular protein transport 
 
In all eukaryotic cells, there is an intricate network for protein transport, as majority 
of the proteins are synthesized in the endoplasmic reticulum (ER) and are then 
transported to different cell organelles of the secretory pathway. The Secretory 
pathway is composed of several organelles and membrane-bound transport 
intermediates, which transport proteins between them. The secretory pathway starts 
at the site of protein synthesis, the ER and proceeds through ER exit site (ERES), 
ER-to-Golgi intermediate compartment (ERGIC) and the Golgi-apparatus 
(Figure.1.1) (Szul & Sztul, 2011). The transport of proteins takes place in specialized 
membrane-bound vesicles, which are formed at the donor compartment and fuse 
with the membrane of the corresponding acceptor compartment, thereby delivering 
the proteins to the acceptor organelles. There are three different classes of vesicles 
depending upon their coat compositions, which mediate protein transport into 
different cellular routes: (1) Coatomer or COP vesicle, (2) Clathrin associated 
transport vesicle (3) non-clathrin associated vesicle. COP vesicles mediate ER to 
Golgi trafficking, while Clathrin-coated vesicle (CCV) mediate protein transport 
between TGN and endosomes and between the plasma membrane and endosomes.  
All newly synthesized membrane proteins are translated at the rough endoplasmic 
reticulum (RER) and are then exported from specialized ER exit sites 
(ERES)(Figure 1.1). With the advent of the latest microscopy techniques and new 
organelle markers, it has been established now that proteins are exported from RER, 
only from specialized ERES. ERES is defined as the smooth projections of ER from 
which COPII vesicles are generated and cargoes are exported. In mammalian cells, 
ERES are formed by fusion and fission of existing ER sites as well as by de novo 
formation of new sites (Stephens, 2003). In mammalian cells, 50-70 ERES of 
approximate 50 μm diameter, are randomly scattered and are relatively stable with 
a life span of >10min (Hammond & Glick, 2000; Stephens, 2003) from which 
COPII vesicles are generated to transport cargo proteins from ERES to ERGIC.  
   9 
 
Figure 1.1 Intracellular Protein transport network:  Scheme representing different compartments 
of secretory and endosomal pathways. Proteins are synthesized in the ER, transported from ERES 
to ERGIC in COPII vesicles. Cargos are than sorted from ERGIC and move to Golgi, for post-
translational modifications. The modified proteins then move through Golgi, and are sorted at TGN 
for delivery to plasma membrane, early and late endosomes and to secretory granules. A retrograde 
pathway mediated by COPI vesicles retrieves proteins from Golgi and returns back to ER. Figure 
adapted from (Szul & Sztul, 2011) 
 
ERGIC, also known as pre-Golgi intermediates, is a collection of vesiculo-tubular 
compartments that are adjacent to ERES. With the help of live microscopy and 
ERGIC markers like ERGIC-53, it has been shown that ERGIC is a stationary 
sorting station, which sorts cargo into the anterograde direction to the Golgi 
apparatus (Ben-Tekaya et al, 2005). In addition to sorting of proteins in the 
anterograde direction to Golgi, ERGIC also sorts cargo in the retrograde direction 
to the ER. The ER and ERGIC resident proteins are sent back to ER from the Golgi 
apparatus or are retained in ERGIC, respectively. The transport of cargos in 
retrograde direction is mediated by COPI coated vesicles  formed at the ERGIC.  
In different cell types, the Golgi complex has a different morphological 
characteristic. In mammalian cells, the Golgi complex is organized in the form of a 
single ribbon of staked cisterna. In C.elegans, D. melanogaster and plant 
A.thaliana, the Golgi complex exists as discrete stacked elements distributed 
throughout the cell, whereas in yeast S.cerevisiae, it exists as discrete tubules 
scattered throughout the cells (Faso et al, 2009). Despite the different 
morphological characteristics of the Golgi complex in different eukaryotic cells, all 
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those Golgi complexes are composed of closely packed membrane cisternae with 
cis Golgi facing towards ER, followed by the medial-Golgi and finally the trans-
Golgi. Several biochemical and microscopic analysis in the past have clearly 
reflected the polarity of the Golgi complex by the localization of certain glycosyl-
transferases as markers. Cis-and-medial Golgi are enriched in early acting enzymes 
of the biosynthetic pathway such as mannosidase I and mannosidase II respectively, 
whereas the trans side has late acting galactosyl-transferase (Velasco et al, 1993; 
Szul & Sztul, 2011). Both cis and trans side have a network of tubules called a cis-
Golgi network (CGN) and trans-Golgi network (TGN) respectively. The CGN 
contains protein transport intermediates, COPII and COPI vesicles, transporting 
proteins between ER and Golgi. The TGN is enriched in clathrin-coated vesicles, 
transporting proteins to endosomes or to the secretory granules (Szul & Sztul, 
2011).  
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1.1.1 COP coated vesicles in early secretory pathway 
 
ER-Golgi transport is mediated by COP (coat protein complex) vesicles formed by 
COPI or COPII protein complexes. COPII vesicles transport proteins from ER in 
the anterograde direction towards Golgi complex, whereas COPI vesicles functions 
in the retrograde direction back to ER. The formation of these vesicles is conserved 
from yeast to mammals and involves coat proteins, Sar1/Arf GTPases and their 
GEFs and GAPs. 
1.1.1.1 COPII mediated anterograde protein transport  
 
COPII vesicles mediate anterograde protein transport. In eukaryotes, a COPII 
protein vesicle is formed by COPII coat proteins: Sar1, Sec23/24, and Sec13/31, 
which polymerize to form a coat and further sort cargo proteins in the coated 
vesicles (Matsuoka et al, 1998; Jackson, 2014). Sar1 is a GTPase present on the 
membrane of ER, which is activated by its GEF (Guanine nucleotide exchange 
factor), Sec12 (Weissman et al, 2001) (Figure.1.2). The activated Sar1 then binds 
directly to Sec23/24 complex of COPII coat and Sec 23/24 in-turn recruits the 
heterotetrameric subcomplex of Sec13/31 to its core and further sort cargo proteins 
for transport in COPII vesicles (Weissman et al, 2001). The sorting of cargo into 
the COPII nascent vesicles is mediated by the sec24 subunit of the COPII and by 
different cargo-specific isoforms of Sec24. Sec24 binds to the cytoplasmic tail of 
the transmembrane cargo proteins. There are four isoforms of sec24: sec24a-d, 
which bind to specific motifs on the cargo proteins and sort them into vesicle for 
transport. Sec24a and Sec24b both bind to DXE and LXXL/ME sorting motifs on 
the cargo protein, while Sec24c and Sec24d bind to the IXM sorting motifs on the 
transmembrane cargo proteins (X refers to any amino acid) (Szul & Sztul, 2011). 
The binding of Sar1 to sec13/31 also ensures, that the vesicle coat is polymerized 
only when the cargo proteins are sorted into the nascent vesicle. After packaging of 
cargo proteins into the nascent vesicle, the vesicle coat polymerizes, which deforms 
the donor membrane, eventually leading to the scission of the vesicle. Detailed 
molecular mechanism for the scission of COPII vesicle remains elusive. However, 
the membrane deformation and scission of the COPII vesicle is most likely to be 
mediated by Sar1 and Sec23/24 complex. Sar1 has been shown to deform the donor 
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membrane in-vitro (Lee et al, 2005) and has been suggested to function in an 
analogous manner to that of dynamin (Pucadyil & Schmid, 2008), which is required 
for the scission of Clathrin-coated vesicles from the donor membrane. Sar1 uses its 
GTP regulated amphipathic N-terminal helix to bind to the donor membrane, 
constricts and deforms it to release the COPII vesicles (Bielli et al, 2005). Inhibition 
of GTP hydrolysis resulted in the formation of COPII vesicles, but these vesicles 
fail to detach from the membrane (Bielli et al, 2005). 
After scission from the donor membrane, the COPII vesicle moves toward the 
acceptor membrane to deliver cargo proteins. When the vesicle comes in close 
approximation to the acceptor membrane, the COPII coat is removed from the 
vesicles and eventually the vesicle tethers to the membrane via SNARE-dependent 
mechanisms. Barlowe and colleagues have studied the tethering of COPII vesicles 
in yeast and have shown that yeast protein Uso1p and a small GTPase, Ypt1p, helps 
in tethering of COPII vesicles to the yeast Golgi (Cao, 1998), (Cao & Barlowe, 
2000). The Uso1p links the COPII vesicles to the Golgi membrane by binding to 
the Golgi proteins, however, the exact binding protein is not certain. The 
mammalian homolog of Uso1p is p115, which binds SNAREs. Thus it could be that 
Uso1p also binds to the known ER-Golgi SNAREs like Bet1, Bos1, Sec22, and 
Ykt6 (Cao, 1998).  
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Figure. 1. 2. Mechanisms of vesicular transport Proteins are transported in the vesicles, which 
bud from the donor membrane, move to the target organelle and fuse with the acceptor membrane 
to deliver the cargo proteins. The initial steps involve the activation of GTPase on the membrane of 
the ER (Sar1) by its GEF Sec21 (step 1). The activated Sar1 recruits the coat proteins (step 2), cargo 
proteins are sorted into the transport vesicle (step 3), and vesicle is scissed from the donor membrane 
following the polymerization of the vesicle coat (step 4). The coated vesicle moves towards the 
target organelle, un-coats (step 5) and tethers to the acceptor membrane via SNARE proteins 
mediated fusion mechanism to the deliver the cargo proteins (step 6). Figure adapted from (Szul & 
Sztul, 2011). 
 
 
There are other proteins as well, which participate in tethering of COPII vesicles. 
Studies in the past have shown that the yeast protein Grh1p, which is closely related 
to GRASP65, is associated with tethering of COPII vesicles by binding to the 
Sec23/Sec24 complex of COPII vesicle coat (Behnia et al, 2007). Grh1p bind with 
coiled-coil protein Bug1p (Bug1p is homologous to mammalian GM130 protein, a 
known interactor of GRASP65) and could possibly be involved in the tethering of 
COPII vesicles. In-vitro studies have shown that Bug1p is required in tethering of 
COPII vesicles (Behnia et al, 2007), however, the exact molecular mechanism is 
not clearly understood.  
 
 
1.1.1.2 COPI mediated retrograde protein transport:  
 
The retrograde protein transport from Golgi to ER and ERGIC is mediated by COPI 
vesicles. The coat of COPI vesicles is formed by heptameric complexes called 
coatomers. The coatomers are composed of two sub-complexes: a trimeric complex 
composed of α, β´ and ε subunits, and a tetrameric complex made of γ, β, δ and ζ 
subunits (Eugster et al, 2000). The X-ray crystallographic structure of COPI coat 
suggests that the trimeric COP complex has structural similarity to the sec13/sec31 
complex of COPII coat (Lee & Goldberg, 2010); γ COP subunit has structural 
similarity to α and β subunit of adaptor protein complex 2 which forms the inner 
core of Clathrin-coated vesicles (Hoffman et al, 2003). Thus, it is proposed that the 
trimeric COP complex (α, β´ and ε) forms the outer coat and that the tetrameric 
complex (γ, β, δ, and ζ) forms the inner core of the COPI vesicles. 
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1.1.2 Clathrin-coated vesicles in late secretory and endocytic pathways: 
 
Clathrin-coated vesicles (CCVs) mediate protein transport in the late secretory 
pathway, between the trans-Golgi network and the early endosomes and between 
the plasma membrane and the early endosomes. Clathrin is a trimeric protein, which 
polymerizes into hexagonal and pentagonal lattices and forms the outer basket of 
the CCV. CCVs are formed at the TGN membrane and at the plasma membrane 
and involve the cumulative interaction of a number of other proteins apart from 
Clathrin. Clathrin does not directly bind to the membrane or to the cargo proteins 
to be transported. At the TGN, the adaptor protein complex 1 (AP1) and at the 
plasma membrane, adaptor protein complex 2 (AP2) binds to the membrane and 
recruits clathrin to the site of vesicle formation and they bind the cargo proteins to 
be transported. 
 
1.1.2.1 Adaptor Protein complexes 
 
In vertebrates, there are five members in the family of adaptor protein (AP) 
complexes, AP1 to AP5. All the adaptor protein complexes are heterotetrameric 
complexes made up of four subunits/adaptins: two large subunits of ≈100kDa each, 
one medium subunit of ≈50kDa and one smaller subunit of ≈20kDa (Figure 1.3). 
All the four subunits are closely associated with each other and detergents are 
required to dissociate them. One of the larger subunits is γ/α/δ/ε/ζ in AP1-AP5 
complexes respectively, which shows limited sequence homology among each 
other. γ subunit of AP1 and α subunit of AP2 show 25% sequence identity 
(Robinson, 1990). The second large subunit is β1-5, in AP1-AP5 complexes 
respectively, which have the highest sequence conservation. β1 and β2 have 84% 
sequence identity (Kirchhausen et al, 1989). The medium subunits are μ1-μ5 and the 
smaller subunits are σ1-σ5 in AP1-AP5 complexes respectively, which share ∼ 40% 
amino acid identity with each other (Thurieau et al, 1988; Nakayama et al, 1991). In 
mammalian cells, there are several isoforms of some of these adaptins, and some of 
them have tissue-specific functions. AP1 complex has two γ isoforms, γ1 and γ2, 
two μ isoforms, μ1A and μ1B and three σ1 isoforms, σ1A, σ1B and σ1C. AP2 
complex has two α isoforms, αA and αC, which are ∼ 80% identical and both are 
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localized on the plasma membrane. AP3 complex has two β isoforms, β3A and β3B, 
two μ isoforms, μ3A and μ3B and two σ isoforms, σ3A, and σ3B (Park & Guo, 2014). 
 
 
 
 
 
 
 
 
 
The AP complexes are localized at different organelles and transport proteins in 
different cellular routes (Figure 1.4). Only AP1 and AP2 complexes recruit clathrin 
and forms clathrin-coated vesicles (CCV) for intracellular protein transport. AP1 is 
localized on TGN and endosomes and mediates protein transport between TGN and 
endosome, particularly in basolateral sorting at epithelial cells (Meyer et al, 2000; 
Yáñez-Mó et al, 2015). AP1 is also necessary for maturation of endocrine, exocrine 
and neuroendocrine secretory granules in Drosophila (Burgess et al, 2011). AP2 
complex is found exclusively on the plasma membrane and transports a wide range 
of proteins including receptors and adhesion molecules via Clathrin-Mediated 
Endocytosis (CME) from the plasma membrane to early endosomes. AP3 is 
localized on tubular endosomes and shuttles cargo from tubular endosomes to late 
endosomes and is essential for the biogenesis of lysosome-related organelles 
(LRO). AP3 also functions with AP1 in sorting of tyrosinase from endosomes to 
melanosomes (Theos et al, 2005), and is also required in the lysosomal sorting of 
Figure 1.3. Diagrammatic representation of Adaptor Protein (AP) complexes: all large adaptins 
have a core domain, hinge and an ear domain except AP5, which lacks a hinge domain. Core 
adaptins bind with cargo proteins and membrane, while hinge and ear domains are required for the 
interaction with coat proteins and accessory proteins. Figure adapted from (Park and Guo, 2014) 
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cargo proteins during the formation of large dense core vesicles (Grabner et al, 
2006). AP4 localizes to TGN and transport cargo between TGN and endosomes and 
to the basolateral plasma membrane. AP5 localizes to the late endosomes and 
transport proteins from late endosome to lysosomes. Dysfunction in any of the AP 
complexes leads to the defect in its respective protein transport routes and are 
associated with a variety of disorders. In our lab, we are interested to study the late 
secretory and endocytic protein transport mediated by AP1 and AP2 complex. 
Therefore, I will focus more on the intracellular transport mechanism mediated by 
AP1 and AP2 complexes. 
  
 
 
 
 
Figure. 1. 4 Scheme showing localization and protein transport routes of different adaptor protein 
complexes. Figure adapted from (Park and Guo, 2014). 
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1.1.2.1.1 AP2 complex 
 
The adaptor protein complex 2 (AP2) is the most studied adaptor protein complex. 
AP2 mediates endocytosis of proteins and receptors at the plasma membrane 
viaclathrin-coated-vesicles (CCV) called Clathrin-mediated endocytosis (CME) 
(see section 1.1.2.3 for CME and CCV formation). The AP2 structure consists of 
two brick-like ‘head’ region flanked by two symmetrically placed appendages or 
ear domains (Figure 1.5). The ear domains are the globular C terminal domain, 
which are separated by a ∼ 6 nm flexible proline-rich, stalk (Figure 1.5) (Damke et 
al, 1994; Owen et al, 2004). The flexible ear domains bind to co-adaptor proteins 
complexes, while clathrin is bound by the core of α and the ear of β2 adaptin (Owen 
et al, 2004). The different subunits of AP2 complex have different essential 
functions in general, and some isoforms of the subunits have tissue-specific 
functions. α and the β2 subunit of AP2 bind to the phosphatidylinositol-4,5-
bisphosphate (PIP2) on the plasma membrane and β2 also bind to the clathrin (Owen 
et al, 2004). μ2 subunit also binds to the PIP2 and to cargo proteins, with tyrosine-
based sorting motifs. σ2 binds only to cargo proteins with di-leucine-based sorting 
motifs (Owen et al, 2004). The binding of α and β2 to the membrane is weak and 
the high-affinity membrane binding of AP2 require it’s binding to the cargos 
proteins as well. The firm binding of AP2 to the membrane is achieved and 
regulated by the conformational change of AP2, which releases a steric hindrance 
of cargo-binding to μ2 and σ2 adaptins It also brings the PIP2 binding motif of μ2 
closer to the membrane. This conformational change of AP2 is favored by the 
phosphorylation of μ2- Thr156 by AAK1 kinase (α adaptin associated kinase) 
(Ricotta et al, 2002; Conner et al, 2003). AAK1 is not the only kinase responsible 
for the phosphorylation of μ2, but the others are not known yet.  
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Figure 1.5 Structure of AP2 Complex: (left-right) Cartoon illustration of the structure of AP2 
complex and the structural model of AP2 complex (α blue, σ2 gray, β2 green, and μ2 purple). This 
structural model is reconstructed from the crystal structure of the core heterotetrameric complex (α, 
β2, σ2 and μ2) (Collins et al, 2002) and the appendage structure (Owen et al, 1999; Owen, 2000). 
The linkers connecting them to the core subunits were drawn to scale. Figure adapted from (Owen 
et al, 2004) 
 
1.1.2.1.2 AP1 complex 
 
The AP1 complexes is expressed ubiquitously like AP2, and mediates protein 
sorting between trans-Golgi network (TGN) and endosomes, which is essential for 
the development of vertebrates (Meyer et al, 2000). There are different types of 
AP1 complexes based on the tissue-specific expression of different subunits of 
AP1. Mammals express 5 different types of AP1/ γ1 complexes (Figure 1.6) with 
tissue-specific functions (Glyvuk et al, 2010; Boehm & Bonifacino, 2001) . There 
are AP1/γ2 isoforms as well (Zizioli et al, 2017), but in this thesis, I will focus only 
on different types of AP1/γ1 complexes. The AP1A complex is ubiquitously 
expressed and is formed by the two large adaptin subunits γ1 and β1 (also known 
as AP1G1 and AP1B1, respectively), one medium subunit μ1A and one small 
subunit σ1A (also known as AP1M1 and AP1S1, respectively). AP1 with μ1B, 
instead of μ1A, is expressed only in polarized epithelial cells (Ohno et al, 1999), 
AP1/μ1B with either σ1B or σ1C isoform instead of σ1A is expressed in the 
polarized epithelial cell, as all the tissue expresses σ1A along with σ1B or σ1C 
isoform (Glyvuk et al, 2010; Ohno et al, 1999). AP1 with σ1B and σ1C isoforms 
instead of σ1A (also known as AP1S2 and AP1S3, respectively) shows 
complementary tissue-specific expression, with most of the tissue expressing 


2
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ubiquitous AP1/σ1A along with either of the other two σ1 isoform complexes, 
AP1/σ1B or AP1/σ1C (Glyvuk et al, 2010). 
In our lab, we are interested in studying the molecular functions of different 
subunits of AP1 in the protein sorting and vesicular protein transport network in the 
cell. The knockout mice of AP1/γ1 are embryonic lethal and die at the age of 3.5 
day post-coitus(p.c), demonstrating the essential role of γ1-adaptin for the viability 
of the mice (Zizioli et al, 1999). The AP1/γ1 deficient mice grew only to the 
blastocyst stage and thus, AP1/γ2 does not compensate for the γ1 deficiency during 
development. There are two-μ1 isoforms of AP1 in mammals, μ1A and μ1B (Ohno 
et al, 1999), and additional μ1C in zebrafish (Gariano et al, 2013). μ1A is 
ubiquitously expressed, whereas the μ1B expression is restricted to the cells of 
polarized epithelial cells (Ohno et al, 1999) and μ1C is expressed only in zebrafish 
(Gariano et al, 2013). The knockout of μ1A gene in mice develops primitive organs 
but dies at the age of 13.5 days (p.c.) (Meyer et al, 2000), demonstrating the 
essential function of μ1A in the viability of the mice. The reason that μ1A-/- mice 
develop primitive organs is most likely due to the homologous isoform μ1B (Ohno 
et al, 1999), and this also indicates that the embryonic survival and organ 
development requires the AP1 complex (Meyer et al, 2000). In the μ1A deficient 
cells, AP1 adaptins are not able to bind to the TGN and clathrin coats are not 
assembled at the TGN (Meyer et al, 2000). However, the AP1 and clathrin binding 
were restored after the re-expression of μ1A, illustrating the critical role of μ1A in 
the binding of AP1 to the TGN (Meyer et al, 2000). In addition, the μ1A deficient 
cells have defects in the distribution of mannose-6-phosphate receptors, MPR46 
and MPR300. Mannose-6-phosphate receptors (MPR) are the cargo molecules, 
which exit the TGN in AP1 CCV. Due to the deficiency of μ1A, the distribution of 
MPR46 and MPR300 was shifted to the early endosomes and both fail to recycle 
back from early endosome to the TGN (Meyer et al, 2000). This defect in MPR 
recycling demonstrate that AP1/μ1A is required for retrograde transport of 
receptors from early endosomes to the TGN (Meyer et al, 2000). 
 As described earlier in this section, three-σ1 isoforms exist: σ1A, σ1B and σ1C. 
σ1A is ubiquitously expressed in all the tissues along with either σ1B or σ1C. 
Mutations in the σ1A gene cause autosomal recessive perinatal lethal  MEDNIK 
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syndrome, characterized by mental retardation, enteropathy, deafness, neuropathy, 
ichthyosis and keratodermia (Montpetit et al, 2008), suggesting the critical role of 
σ1A in the development of the skin and spinal cord. The brain is the tissue with the 
highest expression of σ1B along with σ1A (Figure 1.6) (Glyvuk et al, 2010). The 
knockout mice of σ1B are viable and fertile, but they are hypoactive, have impaired 
motor coordination and have impaired learning and memory (Glyvuk et al, 2010). 
Premature STOP codons in the σ1B gene in humans causes a X-linked mental 
retardation disease, also known as Fried or Pettigrew syndrome (Tarpey et al, 
2006),  also characterized by the hypoactivity and uncoordinated motor functions 
in the patients. The MRI or autopsy studies in few patients with Pettigrew syndrome 
suggest the deposition of iron in the basal ganglia (Cacciagli et al, 2014). Thus, the 
neurological features associated with the deficiencies of σ1A and σ1B could 
probably be due to mislocalization of neuronal AP1 cargos, that specifically 
requires sorting by σ1A and σ1B, respectively. The σ1C isoform is expressed in the 
skin and the mutations in the σ1C gene are associated with severe autoinflammatory 
skin disorder known as Pustular psoriasis, characterized by the disruption of 
endosomal translocation of innate pattern-recognition receptor TLR-3 (Toll-like 
receptor 3) (Setta-Kaffetzi et al, 2014). Thus, the findings associated with the 
Pustular psoriasis, demonstrate the role of AP1/σ1C in Toll-like receptor 
homeostasis.  
 
 
   21 
 
 
Figure 1.6 Cartoon representation of the different types of AP1/γ1 complexes expressed in 
mammals (A) AP1A (ubiquitously expressed) formed by the two large adaptin subunits γ1 and β1, 
one medium subunit μ1A and one small subunit σ1A, (B) AP1A with μ1B, insteadof μ1A, expressed 
only in polarized epithelial cell (Ohno et al, 1999) (C) AP1A/μ1B, with either  σ1B or σ1C 
expressed in polarized epithelial cell (D) AP1A with σ1B isoform  (E) AP1A with σ1C isoforms. 
AP1/σ1B and AP1/ σ1C shows complementary tissue-specific expression, with most of the tissue 
expressing ubiquitous AP1/σ1A along with either of the other two σ1 isoforms, AP1/σ1B or 
AP1/σ1C (Glyvuk et al, 2010). Figure adapted and modified from (Zizioli et al, 2017) 
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1.1.2.2 Clathrin 
 
 
The term clathrin usually refers to the clathrin-heavy-chain (CHC) protein. The 
CHC is a 180 kDa protein: an amino-terminal, β-propeller domain, followed by a 
polypeptide chain of 30 amino acid residue, α helix and C-terminal with 45 residues 
(Fotin et al, 2004) (Figure 1.7). Three CHC molecules are connected at amino-
termini, forming the clathrin triskelion (Fotin et al, 2004; Brodsky, 2012). A second 
clathrin protein is the clathrin-light-chain (CLC) of 20 kDa. The CLC has two 
isoforms in mammalian cells, CLCa and CLCb which, bind with the CHC at the 
vertex of proximal segment and stabilizes the clathrin triskelion basket (Kirchhausen 
et al, 1987; Fotin et al, 2004; Wilbur et al, 2008; Brodsky, 2012). Several clathrin 
triskelia polymerize to form a hexagonal and pentagonal coat structures known a 
‘clathrin cages’. A clathrin cage appears to be a sturdy coat, but actually, it's not. 
The biochemically isolated CCV easily dissociate at physiological pH and could 
reassemble at pH< 6.5, into empty cages even without the interaction of adaptor 
protein complexes (Smith et al, 1998; Fotin et al, 2004). However, in the presence of 
AP complexes, the cage formation is enhanced and allows in-vitro assembly at 
neutral pH (Smith et al, 1998; Fotin et al, 2004). Therefore, CCV isolation at slightly 
acidic pH 6.4 is essential for the clathrin cages to stay intact (Figure 1.7) (Brodsky, 
2012).  
CHC and CLC are both required for the formation of stable clathrin triskelia, 
however, CHC and CLC is not present in a 1:1 ratio and is less than 1 in all tissues, 
with the exception of the brain. In the brain, CHC: CLC ratio is 1.5 and thus, most 
of the clathrin-coated vesicles have not all their CHC binding sites occupied by 
CLC (Kratzke et al, 2014). This altered expression ratio also indicates important 
functions for the interaction of CLC with the actin cytoskeleton. One of the 
biochemical link to explain the interaction of clathrin and actin is the recruitment 
of huntingtin-interacting protein-1 related protein (HIP1R) (Bennett et al, 2001). A 
coiled-coil domain in the center of HIP1R protein binds to the amino terminal of 
CLC, and the carboxy-terminal of HIP1R binds to the F-actin. An amino-terminal 
ANTH domain binds to the membrane (Bennett et al, 2001) and helps in the 
recruitment of HIP1R . 
 
   23 
Besides basket stabilization, CLC binds additional proteins, like the already 
mentioned actin and thus has an additional function besides the regulation of 
clathrin basket stability. CLC knockdown cells suggest mislocalization and 
accumulation of HIP1R proteins in patches near the MPR clusters at TGN and also 
over-assembly of actin filaments (Poupon et al, 2008). Thus, suggesting the 
additional function of CLC in protein sorting, apart from stabilizing the clathrin 
basket. In another study, Ferreira, and colleagues (Ferreira et al, 2012) have 
demonstrated the role of CLC in the endocytosis of a G-protein coupled receptor 
kinase 2 (GRK2). Thus, the functions of CLC are highly dynamic and tissue-
specific. 
 
  
 
 
 
 
 
 
Figure. 1.7 (left-Right) Clathrin triskelion and Clathrin hexagonal coat (only CHCs are depicted for 
simplicity). Figures adapted from (Fotin et al, 2004). 
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1.1.2.3 Clathrin-Coated Vesicle life-cycle 
 
Clathrin-mediated-endocytosis (CME) is the major pathway for the uptake of 
receptors (cargo proteins) from the surface of the plasma membrane, and thus is the 
best model to study the formation of clathrin-coated-vesicle (CCV) life-cycle. CME 
plays an essential role in cell-cell, cell-substrate interactions, intracellular signaling 
and in maintaining cellular homeostasis. CME is the best understood endocytotic 
pathway due to the ease of visualization by TIRF microscopy and live imaging 
techniques. Its concentrative properties and multiple interactions with number of 
proteins have been characterized biochemically and signaling pathways have been 
dissected to understand its relevance in human health and disease (Mettlen et al, 
2018). CME occurs through the formation of clathrin-coated pits (CCPs), by the 
assembly of major clathrin coat proteins comprising of clathrin-heavy-chain 
(CHC), tightly associated clathrin-light-chains (CLCs) and adaptor protein complex 
2 (AP2) (Mettlen et al, 2018). The CME is dissected into four stages: initiations, 
stabilization, maturation and membrane fission (Figure1.8). In the following steps, 
a CCP matures into a CCV and is released from the donor membrane. Fission of 
the CCV is mediated by the GTPase dynamin (Antonny et al, 2016), which is 
recruited at low levels to nascent CCP and presumably taking part in the regulation 
of CCP initiation and maturation step. Fission is achieved by assembling dynamin 
into short helical rings around the neck of the CCP (Mettlen et al, 2018; Antonny 
et al, 2016).  
CME is a very tightly regulated endocytotic pathway and in addition to the major 
coat proteins, a numerous endocytic accessory proteins (EAPs) (see Table 1) which 
functions as scaffolds, cargo recruiters, membrane curvature sensor and generators, 
regulates the CME (Mettlen et al, 2018). Table 1 summarizes the EAPs involved in 
CME and their effects for the formation of CCV. 
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Figure 1.8 Mechanism and regulation of Clathrin-mediated-endocytosis and clathrin coated vesicle 
formation, Figure adapted from (Mettlen et al, 2018) 
 
 
CME is mediated exclusively by AP2 CCVs, which are formed by Adaptor Protein 
complex 2 (AP2) (Figure 1.8). The following model about the molecular 
mechanism regulating CME has been developed over the last two decades. The live-
microscopy analysis in the non-neuronal cells have demonstrated that, not all the 
CCP matures and buds off from the membrane, and those CCP which matures and 
buds from the membrane has a life time of 20-120s (Mettlen et al, 2018) . However, 
at the active zone in the synapses, the rate of endocytosis is much faster than CME, 
the ultrafast endocytosis occurs at the speed of 50-100ms (Watanabe et al, 2013).  
The first step of an AP2 CCV formation is the Initiation stage, where certain EAPs 
like, FCH domain only 1/2 (FCHo1/2) protein, EGFR pathway substrate 15 
(EPS15) and Intersectins, NECAP, CALM and Epsin (Mettlen et al, 2018; 
Stimpson et al, 2009; Henne et al, 2010; Reider et al, 2009) are recruited on the 
plasma membrane. They define the specific sites on the membrane for presence of 
membrane-specific lipids phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) on the 
plasma membrane (Stimpson et al, 2009; Henne et al, 2010; Reider et al, 2009). 
The F-BAR domains of the FCHo proteins have membrane bending activity and act 
like a curvature sensor, required for the progression of CCP (Henne et al, 2010). 
The depletion in any one of these proteins shows defects in the stability of the 
forming clathrin coat. AP2 is recruited to the membrane where AP2 recruits clathrin 
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for the formation of CCP (Stimpson et al, 2009; Henne et al, 2010; Reider et al, 
2009).  
In the stabilization stage, the binding of AP2 to the membrane phospholipid PIP2 
and to cargo proteins is enhanced by its conformational change from a closed to an 
open conformation, in which the C-terminal domain of AP2/μ2 comes in close 
contact to the membrane and binds firmly to PIP2 and the cargo proteins on the 
plasma membrane. This conformational change is favored by the phosphorylation 
of μ2-Thr156 by the AP2 associated kinase, AAK1 (Ricotta et al, 2002; Conner et 
al, 2003). The activity of AAK1 kinase increases at the stabilization stage, ensuring 
the firm binding of AP2 to the membrane (Figure 1.8).  
The third stage is the Maturation stage, during which the CCP grows to its final 
size. Most of the clathrin is recruited from the cytosol by the core adaptor protein, 
AP2 complex. The membrane domains can be coated with AP2 and clathrin and 
only upon trapping of the cargo proteins, the vesicle budding process is initiated. 
Alternatively, high protein concentration of the cargo proteins induce the 
recruitment of AP2 and the formation of CCV (Haucke & De Camilli, 1999). Post 
recruitment of clathrin, clathrin polymerizes into cages at the membrane, and 
mediates membrane bending as the coated pit invaginates (Hinrichsen et al, 2006). 
Following maturation, fission takes place, where CCV buds off from the 
membrane. The budding of CCV from the membrane is mediated by the action of 
a mechanochemical enzyme, dynamin (Kosaka & Ikeda, 1983). Dynamin is 
recruited by the BAR domain proteins like endophilin, amphiphysin and sorting 
nexin 9 (SNX9), to the neck of the vesicle bud. All of these BAR-domain proteins 
have a SRC homology 3 (SH3) domain that binds to the proline-rich domain of 
Dynamin (Wigge et al, 1997; Ferguson et al, 2009; Sundborger et al, 2011). 
According to several studies done in the past, it is suggested that the dynamin 
polymerization around the neck of the vesicle favors GTP hydrolysis (Sweitzer & 
Hinshaw, 1998), leading to conformational changes (Stowell et al, 1999), mediating 
vesicle scission (Roux, A. et al., 2006), (Bashkirov, P. V. et al., 2008). The electron 
microscopy studies of dynamin mediated vesicle fission suggest, that in GTP bound 
state dynamin ring appears to be closely packed, but after GTP hydrolysis, the 
spacing between the dynamin ring increase lengthwise like a ‘spring’ (Stowell et 
al, 1999). This conformational change in dynamin helix might participate in the 
fission of vesicles from the membrane. Mutation or inhibition in dynamin 
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recruitment arrests the formation of the CCV at the vesicle scission stage, 
demonstrating that the activity of dynamin is essential for the scission of the vesicle 
from the membrane (van der Bliek et al, 1993; Macia et al, 2006).  
 
Once the vesicle buds off from its parent membrane, it moves towards its target 
organelle to deliver the protein cargo. Before its fusion with the target membrane, 
the vesicle has to un-coat, so that the membranes come in contact. The uncoating 
stage, of a CCV cycle is demonstrated by two key mechanisms: disassembly of the 
clathrin basket by Heat-shock-cognate 70 (Hsc70), and the dephosphorylation of 
PI-4,5-P2 by the action of phosphatase, Synaptojanin-1 (see section 1.1.2.3.2, for 
the detail mechanism of uncoating of a CCV). The later facilitates the release of the 
AP2 and other co-adaptor proteins, which also bind PIP2. 
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Table 1: List of proteins involved in CME and their effects on CCP and CCV formation. Table 
adapted from (Mettlen et al, 2018). Abbreviations used : A, activation; AP2, adaptor protein-2; 
CALM, clathrin assembly lymphoid myeloid leukemia; CCP, clathrin-coated pit; CHC, clathrin 
heavy chain; CLC, clathrin light chain; Dyn, dynamin; EAPs, endocytic accessory proteins; Eps15, 
EGF-receptor phosphorylation substrate; FCHo1/2, Fer/Cip4 homology domain-only proteins 1/2; 
GAK, cyclin G associated kinase; Hip1R, Huntingtin interacting protein-1 related; Hsc70, heat 
shock protein 70 kD; KD, knockdown; KO, knockout; M, mutation; ND, not determined; NECAP, 
adaptin-ear-binding coat-associated protein; N-WASP, neural Wiskott-Aldrich syndrome protein; 
OCRL, oculocerebrorenal Lowe syndrome protein; OX, overexpression; PI3KC2α, 
phosphatidylinositol 3-kinase C2α; PIP, phosphatidylinositol phosphate; SNX9, sorting nexin 9.   
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1.1.2.3.2 Uncoating of a CCV 
 
While many studies have investigated the CCV budding process using Total 
internal reflection fluorescent (TIRF) microscopy, not much is known about the 
regulation of the lifetime of a CCV. CCVs are transported from the plasma 
membrane into the interior of the cell and thus, they move out of the field observed 
by TIRF microscopy. However, proteins taking part in the disassembly the CCV 
are known and their molecular mechanisms have been studied. There are two key 
mechanisms responsible for the uncoating of a CCV: dephosphorylation of PI-4,5-
P2 by PIP2 phosphatase, Synaptojanin-1, and the disassembly of clathrin basket by 
Hsc70 and its J-domain cochaperones, Auxilin1/2 (Kaksonen & Roux, 2018).  
 
1.1.2.3.2.1 Hsc70 mediated CCV uncoating  
 
Hsc70 is an ATPase protein, which is involved in the uncoating mechanisms of a 
CCV. Rothman lab in 1984 (Braell, 1984; Schlossman, 1984) first reported that 
Hsc70, an abundantly expressed protein is required to disassemble the CCV coat 
before its fusion to the target organelles. Hsc70 is recruited to the CCV by its 
cochaperones, Auxilin1/2. Auxilins have a clathrin basket binding domain and a J 
domain with which it binds to the carboxy-terminal of the clathrin-heavy-chain and 
to the Hsc70: ATP, respectively (Scheele et al, 2003). Auxilin 1, also binds to 
dynamin (Newmyer et al, 2003; Scheele et al, 2003) and thus, mostly recruited to 
the CCV at the time of scission, may contribute to the sequence of fission of vesicle 
followed by uncoating. There are two models proposed to explain the uncoating of 
CCV by Hsc70: Brownian/steric wedge model (Xing et al, 2009) and the wrecking 
ball model (Sousa et al, 2016)  
The “Brownian/Steric Wedge” mechanism (Xing et al, 2009) (Figure 1.9), suggests 
that even in the absence of bound Hsc70 to the clathrin basket, the clathrin coat 
experiences constant fluctuations between the triskelia, but these fluctuations are 
never sufficient to lead to the disassembly of the clathrin basket. However, when 
Hsc70:ATP bind to the C-terminal tails of each CHC vertex, Hsc70 dissociates ATP 
and clamps firmly on CHC, thus sterically blocking the reversal of these 
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fluctuations in the clathrin basket. The blockade is increased with the increase in 
the accumulation of Hsc70, finally to the point where it results in the disassembly 
of the clathrin basket (Xing et al, 2009).  
The “wrecking ball” model suggests that Hsc70 does not act as a passive, steric 
wedge that causes the disassembly of the clathrin basket. Hsc70 are bound to each 
vortex by the association of the flexible polypeptide tethers and such flexible tethers 
allow Hsc70 to generate a disassembling force through its collision to the walls of 
the clathrin coat (Sousa et al, 2016), thus disassembling the clathrin basket from 
inside. The wrecking ball model is the latest model. 
 
 
Figure. 1.9 Schematic representation for the uncoating mechanism mediated by Hsc70. 
Clockwise from upper left side representing the binding of Auxilin to the clathrin coat (red); Auxilin 
recruits Hsc70: ATP( ATPase domain: yellow, substrate binding domain: green); Hsc70 cleaves 
ATP and the substrate binding domain of Hsc70 clamps firmly onto a specific segment of C-terminal 
of clathrin heavy chain which further strains the clathrin lattice; enough number of Hsc70 bound 
with the vertices of clathrin basket generates enough pressure to dissociate the clathrin coat. Adapted 
from (Xing et al, 2009) 
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Once the clathrin coat is disassembled, Hsc70 still remains associated with the 
clathrin triskelia and inhibits the polymerization of the clathrin, required for 
subsequent rounds of CCV formation (Schuermann et al, 2008). Thus, Hsc70 not 
only disassembles the clathrin coat, but it also chaperones the triskelia. Mutations 
in Hsc70 impair the clathrin polymerization and lead to defects in endocytosis 
(Newmyer & Schmid, 2001). Therefore, the chaperoning activity of Hsc70 must be 
regulated, in order to release the Hsc70 from Hsc70:ADP: clathrin, for its 
requirement in endocytosis. Hsc70 nucleotide exchange factors (NEFs) are the class 
of proteins, which regulate the dissociation of Hsc70 from their protein substrates, 
by stimulating the release of ADP from Hsc70:ADP:substrate complex (Packschies 
et al, 1997). The release of ADP allows ATP to bind, which further stimulates the 
release of substrate from the otherwise stable substrate complex. HSP110 is the 
NEF critical for Hsc70 in the clathrin cycle (Sousa & Lafer, 2015). Hsp110 is 
known to be phosphorylated at the serine residue by casein kinase II (CKII) or a 
kinase that has CKII-like specificity (Ishihara et al, 2000). Thus, the activity of 
CKII also plays a role in regulating the CCV uncoating mechanism mediated by 
Hsc70.  
 
 
1.1.2.3.2.2 PI-4,5-P2 dephosphorylation in CCV uncoating  
 
The AP2 requires PI-4,5-P2 on the membrane for its high-affinity binding. Thus, 
dephosphorylation of PIP2 helps in detachment of AP2 from the membrane and 
thus, it is an essential step in uncoating of a CCV (Perera et al, 2006). 
Dephosphorylation of PI-4,5-P2 to PI-4-P and to PI is mediated by PI-4,5-P2 
phosphatase Synaptojanin-1 (McPherson et al, 1996). Synaptojanin-1 has two 
isoforms, which differ in their C terminal domain: ubiquitous Synaptojanin-1 and 
brain-specific Synaptojanin 1 (Perera et al, 2006).  Both Synaptojanins are rapidly 
recruited before the detachment of AP2 CCV from the membrane (Perera et al, 
2006). The knock-out of the brain-specific Synaptojanin-1 encoding gene, Synj1 in 
mice, leads to the accumulation of coated synaptic vesicles as well as of PI-4,5-P2 
in the neurons, suggesting that the role of Synaptojanin-1 is essential in uncoating 
of vesicles  (Cremona et al, 1999). The role of Synaptojanin-1 in fibroblast cells 
also suggests that it plays an important role in clathrin-coated vesicle cycle, as the 
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depletion of Synaptojanin-1 from the plasma membrane in the fibroblast cells 
depletes the available clathrin pool and completely stops the formation of clathrin-
coated pits (Zoncu et al, 2007). Furthermore, the disruption of PI-4,5-P2 synthesis 
impairs the formation and trafficking of synaptic vesicles in the nerve terminals of 
mice (Paolo et al, 2004), suggesting the role of PI-4,5-P2 synthesis in the regulation 
of the synaptic vesicle cycle.  
Apart from Synaptojanin, another PI-4,5-P2 phosphatase, inositol polyphosphate 5-
phosphatase OCRL1 (encoded by OCRL), was identified to be directly involved in 
clathrin-mediated endocytosis (CME) (Erdmann et al, 2007) and regulates protein 
trafficking between early endosomes and TGN (Choudhury et al, 2005). OCRL1 
interacts directly with clathrin and AP2 and is assumed to act after dynamin-
mediated scission and participate in dephosphorylation of PI-4,5-P2 (Choudhury et 
al, 2005; Ungewickell et al, 2004).  
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1.2 Synapse and Synaptic Vesicle recycling 
 
Chemical synapses, the site of neuron-to-neuron signal transmission is formed 
between a ‘pre-synapse’, which releases the neurotransmitters, and the receiving 
target synapse is the ‘post-synapse’. There is a gap between pre-and post-synapse 
called a ‘synaptic cleft’, into which the neurotransmitter molecules are released. 
The efficacy, with which the neurotransmitter molecules are transmitted between 
pre-post-synapse, is crucial for the function of the nervous system.   
The neurotransmitters are packed in small (∼50 nm) round, seemingly identical 
organelles called as ‘Synaptic Vesicles’ (SV) (Mundigl & De Camilli, 1994; 
Rizzoli, 2014). SV are specialized secretory organelles, which mediate fast and 
local signaling in the nerve cells. Neurotransmitters such as glutamate, γ-
aminobutyric acid (GABA) and acetylcholine are filled in the SV (Mundigl & De 
Camilli, 1994). At the pre-synaptic plasma membrane, the synaptic vesicles fuse at 
the specialized area called ‘active zone’ upon the stimulus received by the influx of 
Ca+2 ions, they release the neurotransmitter molecules (exocytosis) (Rizzoli, 2014). 
The synaptic vesicle protein Synaptotagmin1 (syt1), a well-known calcium sensor, 
binds incoming Ca+2 and release the block of the vesicle fusion (Hui et al, 2009). 
The released neurotransmitter molecules diffuse across the synaptic cleft and bind 
to the receptor of the post-synaptic membrane leading to the activation or inhibition 
of post-synaptic signaling events. Following exocytosis, the SV components are 
immediately retrieved from the plasma membrane to enable the reformation of SV 
for the subsequent round of exocytosis. In 1973, Heuser and Reese have suggested 
the term ‘synaptic vesicle recycling’ for this process of exocytosis and endocytosis, 
required for the release of neurotransmitter. Synaptic vesicle recycling mechanisms 
has been extensively studied since then and is one of the best-studied cellular 
pathways. Many of the proteins involved in synaptic vesicle recycling have been 
identified and their functions becoming clear over time. However, the complete 
understanding of the synaptic vesicle-recycling pathway as a whole is still difficult 
and is on the progressive side with the advancement of the latest research 
techniques. 
The complete synaptic vesicle cycle is a complex process and involves the 
interaction of a number of proteins. The studies of the synaptic vesicle have 
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revealed that one synaptic vesicle, contains about 1500-2000 neurotransmitter 
molecules and most of the SV proteins are present in multiple copy numbers per 
vesicle {Takamori: 2006jz}. Only few proteins, like synaptic vesicle 2-related 
protein (SV2) and the V-ATPase are present in only one or two copies in a single 
vesicle (Takamori et al, 2006). This study demonstrates the diversity of proteins 
contained in one single synaptic vesicle. The synaptic vesicle displays functional 
specializations, which demonstrates the existence of more than one type of synaptic 
vesicle pool in the pre-synaptic terminal. The ultrastructure studies of pre-and post-
synaptic membranes have revealed the presence of clusters of synaptic vesicles in 
the pre-synaptic nerve terminal, which participate in the exo-and endocytosis cycle 
(Rizzoli, 2014; Truckenbrodt & Rizzoli, 2014). The classical three-pool model, 
suggest that there are three different pools of SV: the readily releasable pool (1–2% 
of all vesicles) which, provides fast initial neurotransmitter release, the recycling 
pool (10-20%) that, maintains the neurotransmitter release during physiological 
levels of stimulations, and the reserve pool (~80 %), which is inert in terms of 
neurotransmitter release under physiological stimulation protocols (Truckenbrodt 
& Rizzoli, 2014; Rizzoli, 2014). The extent to which, the reserve pool participate 
in the neurotransmitter release during the sustained period of high-level activity is 
not clearly understood. However, the mobilization of the reserved pool could be 
controlled by the cell division protein kinase 5 (CDK5), in the mammalian cells 
(Kim & Ryan, 2010). CDK5 is a kinase known for its function in the nervous system 
and is involved in post-synaptic signaling mechanism (Kim & Ryan, 2010). The SV 
numbers and pool sizes are not dependent on the number of active zones and are 
almost similar in different glutamatergic synapses, like with 2 active zones in 
hippocampal synapse or 500-600 active zones in the calyx of Held (a large 
glutamatergic nerve terminal in the auditory pathway) (Neher, 2010). This 
demonstrates that the vesicle supply is not the limiting factor in the release of 
neurotransmitter, rather the availability of release site, is the limiting factor during 
sustained synaptic activity (Neher, 2010). 
During the synaptic vesicle cycle (Figure. 1.10), the neurotransmitter-filled 
synaptic vesicles are docked and primed at the active zone (AZ). The binding of SV 
and AZ SNARE proteins, facilitates the priming of the synaptic vesicle. Before the 
fusion of synaptic vesicle, there is a coupling between Synaptobrevin (a synaptic 
   35 
vesicle transmembrane protein) and the plasma membrane SNARE protein, 
synaptosome-associated protein, SNAP25 (Haucke et al, 2011). The SNARE 
Syntaxin is also a part of the fusion controlling SNARE complex. The activity of 
the SNAREs is tightly regulated by the activity of two key proteins, Munc13 and 
Munc18, which are also involved in the priming of the SV. The neurotransmitter 
release is triggered by the influx of Ca+2, through the calcium channels located at 
the AZ. 
 
 
 Figure 1.10 Illustration of synaptic vesicle cycle: a.) Synaptic vesicles (SV) from the readily 
accessible pool is docked and primed near the active zone, b.) Following Ca+2 influx, the SV undergo 
exocytosis and release the neurotransmitters. The exocytosis preferable occurs at the specialized 
area on the pre-synaptic membrane, known as ‘active zone’, characterized by the presence of Ca+2 
channels and scaffolding proteins of the cytoplasmic matrix of active zone (CAZ), c.) After 
exocytosis, the SV proteins, as well as SV membranes, are endocytosed preferentially within the 
periactive zone that surrounds the active zone, d.) Clathrin-mediated endocytosis by Adaptor Protein 
complex 2 and dynamin-dependent pathways predominantly mediate SV endocytosis, e.) Following 
clathrin uncoating and neurotransmitter uptake, the SV returns to the recycling pool for next round 
of exocytosis. Figure adapted from (Haucke et al, 2011). 
 
 
 
The fusion of synaptic vesicles is induced by the steep rise in the levels of Ca+2, 
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leading to the exocytosis of neurotransmitters. The vesicle protein, Synaptotagmin1 
(syt1), senses the Ca+2 and bends the membrane during fusion of the vesicles (Hui 
et al, 2009). Many other important proteins regulate the fusion of the vesicles 
including the Rabs and complexins. Complexins are high affinity SNAREs-
binding, synaptic proteins, which regulates the post-priming events during 
neurotransmitter release (Xue et al, 2007). A study done in the past suggests that 
Complexin I (CplxI) binding to the SNARE complex via its central α helix is 
necessary, but not sufficient alone for its function in the release of neurotransmitter 
(Xue et al, 2007). There is an accessory α helix, on the N terminal side of the 
SNARE complex-binding region of CplxI, which, has an inhibitory effect in the fast 
synaptic exocytosis. However, the sequences adjacent to this helix facilitate 
Calcium-dependent exocytosis, even in the absence of synaptotagmin-1. Thus, the 
distinct functional domains of Complexin I, regulate the synaptic exocytosis and 
play a key role in fine-tuning of the events during the fast release of 
neurotransmitters (Xue et al, 2007). 
After the fusion of the membrane, the assembled SNARE complexes are 
disassembled and their components are resorted as per their destinations, in order 
to maintain the subsequent rounds of vesicle release. For example, Synaptobrevin 
is separated from its SNARE complex, sorted, translocated and then endocytosed. 
The disassembly of the SNARE complex is an energy-dependent procedure and 
requires the involvement of the specialized ATPase NSF and its adaptor protein, 
the α-soluble NSF attachment protein (α-SNAP) (Galli & Haucke, 2004; Südhof & 
Rothman, 2009). Thus, these steps constitute the kinetic bottleneck and are the rate-
limiting step for the efficiency of endo-exocytosis coupling in the synapse. 
Following the exocytosis of synaptic vesicle and the release of neurotransmitters, 
the SV proteins are endocytosed and are recycled for the next round of synaptic 
vesicle release (Südhof, 2004).  
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1.2.1 AP1 and AP2 in the synapse 
 
 
AP1 and AP2 functions are indispensable for the survival and embryonic 
development of mammals. Of all the AP1 knockout mice generated in our lab, only 
AP1/σ1B mice were viable and fertile, but have severe defects pertaining to nervous 
system development and brain functions (see section 1.1.2.1.2 on AP1 complex) 
(Meyer et al., 2000; Glyvuk et al., 2010; Zizioli et al., 1999). This suggests the 
essential role of AP1 in embryonic survival as well as in brain development. In 
addition, the conditional AP2 knockouts demonstrate the indispensable functions 
of AP2 in neurons (Saheki & De Camilli, 2012; Kononenko et al, 2014) (see section 
1.1.2.1.1 on AP2 complex for details) 
 
Vesicular protein transport is most active in synapses, the site of neuron-to-neuron 
signal transmission (see section 1.2 on synapse and synaptic vesicle recycling for 
details). While the ‘post-synapse’, a specialization of the dendrite of the neuron, is 
most active in signal transduction pathways, the pre-synapse is the site of highly 
active vesicular membrane trafficking. Pre-synapse is filled with the SV, which fuse 
upon neuron stimulation with the plasma membrane at the specialized, active zones, 
releasing neurotransmitters into the synaptic cleft, where they bind to their receptors 
on the post-synaptic membrane (see section 1.2 for the detailed steps of 
neurotransmitter release) 
 
The synaptic vesicle has to be endocytosed to be reformed and refilled with the 
neurotransmitters to enable the synapse for multiple rounds of signal transmission. 
The AP2 functions in this pathway of synaptic vesicle endocytosis. Due to the high 
turnover of synaptic vesicles in the neurons, the nerve terminals have developed an 
efficient endocytic mechanism to recapture and reuse the SV. AP2 mediated CME 
plays a major role in the internalization of synaptic vesicle proteins and it has been 
suggested that SV could be derived directly from the uncoating of AP2 CCV (Saheki 
& De Camilli, 2012; Kononenko et al, 2014). Kononenko, and colleagues (Kononenko 
et al, 2014) have demonstrated that AP2/clathrin, in addition to their role at the 
plasma membrane are also operational at the internal endosome like vacuoles, to 
regenerate synaptic vesicles but are not the only mechanism for membrane retrieval. 
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They have demonstrated this by conditional knockouts of μ2 adaptin of AP2 
complex. 
 
In another study done in our lab, Kratzke and colleagues (Kratzke et al, 2014) have 
demonstrated evidence for SV recycling via AP2 CCV and via early endosomes. 
They have studied this mechanism in the of AP1/σ1B-/- knockout mice, which have 
reduced synaptic vesicle recycling and increased endosome accumulation in the 
hippocampal synapses (Glyvuk et al, 2010; Kratzke et al, 2014). The accumulated 
endosomes were isolated by M. Kratzke and biochemically characterized. They 
were identified as phosphatidylinositol-3-phosphate (PI-3-P) positive classic early 
endosomes. The σ1B-deficiency induces alterations in synaptic vesicle protein 
numbers and their sorting into the endolysosomal pathway (Kratzke et al, 2014). 
There are certain proteins like tetraspanins, which are selectively enriched in σ1B-
/- synaptosomes, but not in their endosome and or CCVs, suggesting AP1/σ1B-/- 
dependent protein sorting (Kratzke et al, 2014). Synapses of AP1/σ1B−/− mice 
contain twice as much AP2 CCV compared to the wild-type, which is surprising as 
they contain less synaptic vesicles due to inefficient synaptic vesicle recycling. 
These AP2 CCV were also biochemically characterized and have a different coat 
composition suggesting altered CME (Kratzke et al, 2014). These data demonstrate 
a direct connection between AP2 mediated endocytosis and AP1/σ1B-mediated SV 
reformation (Kratzke et al, 2014).  
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1.2.2. AP1/σ1B functions in synaptic vesicle recycling 
 
The σ1B adaptin is encoded by σ1B gene present on the X-chromosome in mice 
and in humans. In order to study the specific function of σ1B in the vesicular 
transport network, AP1/σ1B knockout mice were generated in the lab by a targeted 
mutation in the σ1B locus. A genomic fragment of the X-chromosomal σ1B locus 
was isolated, mutated, and introduced into the 129SV/J mouse line and crossed with 
C57/B16 animals to generate the σ1B-/- mouse model (Glyvuk et al, 2010).  
Unlike the knockouts of other subunits of AP1, σ1B knockout mice were viable and 
fertile, but the behavioral studies revealed that the knockout mice were hypoactive, 
have impaired motor coordination and learning and spatial memory is also 
perturbed (Glyvuk et al, 2010). Human studies have also revealed that patients 
suffering from severe X-linked mental retardation disease, have a premature stop 
codon in the σ1B gene (Tarpey et al, 2006). The patients are hypoactive, have 
impaired motor coordination, learning and memory. They learn to walk at the age 
of 4-6 years and are not able to develop any intelligible language capabilities and 
require lifelong comprehensive care (Tarpey et al, 2006). Thus, σ1B knockout mice 
are also the animal model to study X-linked mental retardation disorder. 
Our mouse phenotypes suggest the involvement of σ1B in the vesicular transport 
of synaptic proteins, which are responsible for brain function. Hippocampal 
synapses were studied in detail, because hippocampus is the site of memory 
formation and is associated with motor learning and coordination. The analysis of 
the hippocampal synapses revealed a slower and incomplete SV recycling rate and 
the accumulation of endocytic membranes (Figure 1.10) (Glyvuk et al, 2010). In the 
hippocampal synapse, SV recycling was measured after stimulation by 600 AP/10 
Hz (AP: action potential; Hz: Hertz). Within the first 10s after stimulation, only 
45% of the exocytosed material was retrieved in knockout synapses compared to 
90% in wild-type controls (Figure 1.10), demonstrating slower synaptic vesicle 
recycling (Glyvuk et al, 2010). In addition, SV recycling was incomplete, because 
only 70% of the SV were reformed by this altered recycling pathway (Glyvuk et al, 
2010). 
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Fig. 1.10. Delayed SV re-priming after full depletion of the total recycling SV pool by 600 AP/50 
Hz stimulation. Within the first 10s after stimulation, only 45% of the exocytosed material was 
retrieved compared with 90% in wild-type controls and only 70% SV were reformed (Adapted from 
(Glyvuk et al, 2010). 
 
 
The morphological characterization of the hippocampal synapses by electron 
microscopy (Figure 1.11) revealed a decrease in the number of synaptic vesicles in 
the knockout synapse compared to the wild-type, in line with reduced synaptic 
vesicle recycling rate (Glyvuk et al, 2010). Surprisingly, there were accumulations 
of large endosomes and CCVs in the knockout synapse, despite of fewer synaptic 
vesicles and slower synaptic vesicle-recycling rate (Figure 1.11).  
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Figure.1.11 3D-reconstruction of electron microscopy images of synapses: (A, B) wild-type and (C, 
D) AP1/σ1B-deficient synapses. In (A) and (C) synaptic vesicles are excluded for clear 
visualization. Figure adapted from (Glyvuk et al, 2010) 
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1.2.3. Synaptic Plasticity and AP2 functions in the Synapse 
 
As discussed in section 1.2.2, the σ1B knockout synapses have fewer synaptic 
vesicles and slower synaptic vesicle-recycling rate, however, they have an 
accumulation of large endosomes and AP2 CCV. The study done by Kratzke and 
colleagues in our lab, (Kratzke et al, 2014) developed a protocol to separate these 
accumulated endosomes from the majority of neuronal endosomes. The 
biochemical characterization of these accumulated endosomes revealed that they 
were actually classic early endosomes with an increase in phosphatidylinositol 3-
phosphate (PI-3-P), to which proteins bind, which mediate protein sorting out of 
early endosomes into different protein transport routes. Due to AP1/σ1B-
deficiency, there was an alteration in the endosomal protein-sorting pathway. About 
two-thirds of the synaptic vesicle proteins were reduced in the σ1B-/-synapse and 
the Multivesicular-body (MVB) pathway for degradation of proteins was up-
regulated, indicating that the majority of SV proteins are indeed degraded via this 
endolysosomal pathway.  
Endosomal recycling pathways were not up-regulated, but specific SV proteins like 
tetraspanins were misrouted and accumulated in σ1B knockout synaptosomes, but 
not in their endosomes or CCVs, indicating AP1/σ1B dependent protein sorting 
(Kratzke et al, 2014). The accumulated CCVs in the σ1B knockout synapses were 
also biochemically characterized. These accumulated CCV were not non-
functional/crippled AP1 CCV, as one would expect because of the missing σ1B 
subunit of AP1, rather they were AP2 CCV (Kratzke et al, 2014). The increase in 
AP2 CCV in the AP1/σ1B-/- synapses is a secondary phenotype of σ1B deficiency, 
suggesting a link between AP1 regulated protein sorting and exocytosis with AP2 
regulated endocytosis. Thus, the characterization of hippocampal synapses not only 
revealed the function of AP1/σ1B in SV protein sorting in the synapse, but also in 
AP2 dependent CME. The accumulation of early endosomes and endocytotic AP2 
CCV indicates the regulation of SV recycling via early endosomes and as well as 
by interdependent regulation of AP2 mediated endocytosis and AP1/σ1B mediated 
SV reformation. 
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Figure 1.12. Scheme summarizing the alterations in SV protein trafficking in AP1/σ1B knockout 
synapses: The knockout synapses have fever SV, but shows an increase in endocytic AP2 CCV, and 
early endosome accumulation. Their maturation of early endosomes into late multi-vesicular-body 
endosomes is up-regulated, but other protein export routes out of early endosomes are not up- 
regulated, suggesting that the degradation of the one-third of the synaptic vesicle proteins are 
mediated via endolysosomal pathway. Scheme adapted from (Kratzke et al, 2014). 
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1.2.4. Maturation of early endosomes is regulated by AP1/σ1A and AP1/σ1B 
 
There are two isoforms of σ1 adaptin and thus AP1 complexes expressed in the 
brain: AP1/σ1A and AP1/σ1B, having 87% sequence homology. Both of the 
isoforms bind cargo proteins with di-leucine-based sorting motifs but sortilin is 
exclusively bound by σ1B (Baltes et al, 2014; Poirier et al, 2013; Glyvuk et al, 2010). 
AP1/σ1A is essential in the development of brain, whereas σ1B plays an important 
role in synaptic vesicle recycling (Glyvuk et al, 2010; Meyer et al, 2000; Kelly et al, 
2008). Mutations in σ1A in humans, cause defects in the development of skin and 
spinal cord and the patients die post-natally (Montpetit et al, 2008). σ1A knock-out 
mice die in-utero and the few born, die perinatally (Schu, unpublished). Thus, 
AP1/σ1A and AP1/σ1B are required for the neuronal development and function. 
In the σ1B knockout synapses, there was an accumulation of early endosomes and 
of AP2 CCV (as discussed in section 1.2.3). The study done in our lab by Candiello 
and colleagues (Candiello et al, 2016) demonstrates that AP1/σ1A and AP1/σ1B 
regulate the maturation of the accumulated early endosomes into multivesicular 
body (MVB) late endosomes, thereby controlling synaptic vesicle protein transport 
into a degradative pathway (Figure 1.13). The maturation of MVB is regulated by 
the formation of a tripartite complex made of AP1/σ1A-ArfGAP1-Rabex5. 
ArfGAP1 is the GTPase, which activates Arf1GTP. There are two isoforms of 
ArfGAP 1 expressed in the brain: ubiquitous ArfGAP1 and brain-specific 
ArfGAP1. The tripartite complex formation is most efficient with brain-specific 
ArfGAP1. Rabex5 is a Rab5 GDP-GTP exchange factor. Rab5 activates Vps34, a 
PI 3-kinase (PI3KC3) (Stack et al, 1993) whose activity is essential for  the formation 
of multivesicular body endosomes (Kratzke et al, 2014; Backer, 2008). Upon binding 
of σ1A, ArfGAP1 binds Rabex5 and form a stable AP1/σ1A-ArfGAP1-Rabex5 
complex, leading to more endosomal Rabex5. This enhances the Rab5GTP-
stimulated Vps34 PI3-kinase activity, which is essential for multivesicular body 
endosome formation. σ1B binds Rabex5 and inhibits AP1/σ1A-ArfGAP1-Rabex5 
complex formation thus, limiting the stable recruitment of Rabex5, further 
hindering the formation of MVB endosomes. Thus, AP1/σ1A and AP1/σ1B adaptor 
proteins differentially regulate the neuronal early endosome maturation into the 
multivesicular body via the Rab5/Vps34 pathway (Candiello et al, 2016). Also, in the 
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Alzheimer’s and Parkinson’s diseases, the sorting of endosomal proteins are 
disturbed and thus the novel function of AP1 could be important for the 
understanding of the molecular mechanism of these diseases as well.  
 
 
 
 
 
 
 
 
 
 
Figure 1.13. Model for AP1/σ1A and AP1/σ1B mediated regulation of SV protein degradation via 
the multivesicular body late endosome (MVB) pathway. The MVB maturation is upregulated by the 
formation of AP1/σ1A-ArfGAP1-Rabex5 complex in AP1/σ1B knock-out synapses and the 
subsequent stimulation of the stable Rab5/Vps34 . Model adapted from (Candiello et al, 2016).  
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Aim of the study 
 
 
The aim of this study was to answer the questions stipulated by the phenotypes of 
AP1/σ1B knockout mice. The synapses of AP1/σ1B knock-out mice contains two 
times more AP2 and endocytosis mediating AP2 CCV than wild-type synapses, 
despite of a slower synaptic vesicle recycling rate and fewer synaptic vesicles. In 
addition, it was not known whether these phenotypes are synapses specific, or 
whether they are a more general phenomenon of σ1B deficiency.  
 
The specific molecular mechanism for the accumulation of AP2 CCV has to be 
understood. The increase in AP2 CCV could be due to an increase in clathrin-
mediated endocytosis, or it could be due to the extended lifetime of the AP2 CCV, 
thus leading to an accumulation of AP2 CCVs. However, these mechanisms are not 
exclusive of each other and could operate at the same time. The aim of this project, 
was to identify a molecular mechanism responsible for the accumulation of AP2 
CCVs and also of their functions in the AP1/σ1B -/- synapses. 
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Chapter 2: Material and Methods 
 
 
2.1. Specific lab Equipments 
 
Equipment Manufacturer 
Sonicator 220F Heat System ultrasonic, QC Canada 
Intelligent Dark Box II, LAS 100 Fujifilm, Japan 
Gradient Station IP Biocomp, Canada 
Confocal Scanning Microscope SP2 Leica Bensheim, Germany 
UV-Visible Spectrometer (Varian Cary 
50 Bio) 
Conquer Scientific, USA 
Western Blot unit Bio-Rad, Germany 
SDS page Unit  Bio-Rad, Germany 
Standard Power Pack P25 Biometra, Germany 
Cell homogenizer  Isobiotech, Germany 
Glass porter homogenizer Wheaton, USA 
 
2.2. Chemical, buffers and solutions: 
 
All the buffers and solutions were prepared in Ultra-pure deionised water (Gen 
Pure Recovered, TKM, Germany). 
 
   48 
Solutions Source 
 2.2.1. Clathrin Coated Vesicle (CCV) Isolation 
Buffer:  
 
10mM MES   AppliChem, Germany 
0.5mM EGTA  Sigma, Germany 
0.5mM MgCl2  Merck, Germany 
320mM Sucrose  Carl Roth GmbH, 
Germany 
1mM Na3VO4 Sigma, St. Louis, USA 
10mM NaF  Sigma, St. Louis, USA 
10nM Calyculin A Abcam, Cambridge, UK 
Protease Inhibitor Cocktail Sigma, St. Louis, USA 
pH 6.4  
2.2.2. SDS Poly-Acrylamide Gel Electrophoresis 
(PAGE): 
 
2.2.2.1. Stacking gel Buffer:  
 
0.5 M Tris/HCl  Carl Roth GmbH, 
Germany 
0.4% (w/v) Sodium dodecyl sulfate  (SDS)  SERVA GmbH, 
Germany 
pH 6.8  
2.2.2.2. Running gel Buffer: 
 
1.5 M Tris/HCl  Carl Roth GmbH, 
Germany 
0.4% (w/v) Sodium dodecyl sulfate (SDS) SERVA GmbH, 
Germany 
pH 8.8  
2.2.2.3. Rotiphorese®-Gel30: Acrylamide-
/Bisacrylamide  
Carl Roth GmbH, 
Germany 
 2.2.2.4. APS: 10% (w/v) Ammonium peroxodisulfate  
Merck, Germany 
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2.2.2.5. TEMED: N,N,N′,N′ Tetramethyl 
ethylenediamine 
 
SERVA GmbH, 
Germany 
2.2.2.6. Running Buffer:  
 
50mM Tris  Carl Roth GmbH, 
Germany 
400mM Glycine  Carl Roth GmbH, 
Germany 
0.1%(w/v) Sodium Dodecyl Sulfate  SERVA GmbH, 
Germany 
pH 8.6  
2.2.2.7. 6x reducing sample buffer:  
 
750mM Tris/HCl  Carl Roth GmbH, 
Germany 
9% (w/v) Sodium Dodecyl Sulfate  SERVA GmbH, 
Germany 
1% (v/v) Bromophenol blue  Merck, Germany 
60% (v/v) Glycerol  Sigma-Aldrich, Germany 
50mM DTT  AppliChem, Germany 
pH 6.8  
2.2.2.8. Protein molecular weight marker:  
 
Precision Plus Protein Standard All Blue (250kDa-
10kDa), catalog#1610372 
Bio-Rad, Germany 
2.2.2.9. Nitrocellulose membrane  
GE healthcare, 
Netherland 
2.2.3. Semi-Dry Western Blots: 
 
2.2.3.1. Anode Buffer:  
 
75mM Tris/HCl  Carl Roth GmbH, 
Germany 
20% Methanol  AppliChem, Germany 
pH 7.4  
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2.2.3.2. Cathode Buffer:  
 
40mM Aminocaproic Acid  Carl Roth GmbH, 
Germany 
20mM Tris/HCl  Carl Roth GmbH, 
Germany 
20 % Methanol  AppliChem, Germany 
pH 9.0  
2.2.3.3. TBS (Tris-buffered saline):  
 
100mM Tris/HCl  Carl Roth GmbH, 
Germany 
100mM NaCl  AppliChem, Germany 
pH 7.5  
2.2.3.4. TBST (Tris buffered saline with Tween 20) 
 
100mM Tris/HCl  Carl Roth GmbH, 
Germany 
100mM NaCl  AppliChem, Germany 
0.05% Tween 20  AppliChem, Germany 
pH 7.5  
2.2.3.5. Blocking Solution 
 
5% Skimmed milk powder in TBST Ferma Reform, GmbH, 
Germany 
2.2.3.6. Chemiluminescence ECL kit 
 
SuperSignal West Pico Plus chemiluminescent Substrate  Thermo Scientific, USA 
SuperSignal West Femto Plus chemiluminescent 
Substrate  
Thermo Scientific, USA 
SuperSignal West Dura Plus chemiluminescent Substrate  Thermo Scientific, USA 
2.2.3.7. Stripping Buffer (for 1L) 
 
15% Glycine Carl Roth GmbH, 
Germany 
1% SDS  SERVA GmbH, 
Germany 
0.1% Tween20  AppliChem, Germany 
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pH 2.2  
2.2.4. MEF Cell Culture Media and Solutions: 
 
2.2.4.1. PBS (Phosphate-buffered saline):  
 
140mM NaCl  AppliChem, Germany 
2.5mM KCl  Carl Roth GmbH, 
Germany 
6.5mM Na2HPO4  Carl Roth GmbH, 
Germany 
1.5mM KH2PO4  Carl Roth GmbH, 
Germany 
pH 7.4  
2.2.4.2. Trypsin-EDTA Solution:  
 
0.5 g/L Trypsin Gibco Invitrogen, 
Germany 
0.2 g/L EDTA  Gibco Invitrogen, 
Germany 
2.2.4.3. Growth Medium:  
 
4.5 g/L Dulbecco´s Modified Eagle Medium (DMEM)  Gibco Invitrogen, 
Germany 
10%(v/v) Fetal Calf Serum (FCS) PAN, Germany 
1%(v/v) Penicillin/Streptomycin (100x Stock solution)  Gibco Invitrogen, 
Germany 
1%(v/v) Glutamine (200mM, 100x Stock solution) Gibco Invitrogen, 
Germany 
2.2.4.4. Freezing Medium:  
 
4.5 g/L Dulbecco´s Modified Eagle Medium (DMEM)   Gibco Invitrogen, 
Germany 
10%(v/v) Fetal Calf Serum (FCS) PAN, Germany 
5%(v/v) Dimethyl sulfoxide  Fluka, Germany 
1%(v/v) Penicillin/Streptomycin (100x Stock solution)  Gibco Invitrogen, 
Germany 
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1%(v/v) Glutamine (200mM, 100x Stock solution)  Gibco Invitrogen, 
Germany 
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2.3. Protein extract preparations 
 
2.3.1. Preparation of protein extracts from murine brain cortices 
 
The wild-type and knockout murine brains were excised and flash froze in liquid 
Nitrogen   (-196ºC) and stored at - 80ºC until the experiment. The knockout and 
wild-type cortices preparations were always done in parallel on the same day to take 
into account any differences based on sample preparation. On the day of the 
experiment, one brain at a time was thawed on ice, cerebellum with brain stem was 
removed and cerebral cortex was sliced with a scalpel in 1.5 ml of CCV buffer (see 
section 2.2.1). The sliced cortex was transferred to a glass porter and was 
homogenized with "Loose Piston" until no visible pieces of tissue sample were 
observed, followed by "tight Piston" until reduced resistance was felt. The 
homogenized cortices were centrifuged at 1000x g for 10 minutes; supernatant (S1) 
was separated and stored in an Eppendorf and pellet (P1) was resuspended in 1 ml 
of CCV buffer and centrifuged again at 1000x g for 10 minutes. The supernatant 
(S2) was isolated and combined with S1; pellet (P2) was discarded. The combined 
supernatant (S1+ S2) contains proteins from brain cortex. The protein 
concentrations of the extracts prepared was determined by Bradford Assay (see 
section 2.5.1) and were biochemically characterized by semi-quantitative western 
blot analysis (see section 2.5.2). 
2. 3.2. Isolation of synaptosomes from brain cortex extracts 
 
The brain cortex extracts were prepared as described in section 2.3.1 and the 
synaptosomes were separated from the whole brain cortex by differential 
centrifugation. The cortex extract (S1+S2) was centrifuged at 9200x g for 15 
minutes; the supernatant was discarded and the pellet was resuspended in 1.5 ml of 
CCV buffer and centrifuged at 10200x g for 15 minutes. The supernatant was 
discarded and the pellet containing synaptosomes was resuspended in 700 µl of 
CCV buffer and stored for further biochemical characterization. 
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2.3.3. Isolation of synaptic Clathrin-coated vesicles 
 
Clathrin-coated vesicles (CCVs) were isolated from synaptosomes prepared in 
section 2.3.2. The Clathrin coat of a CCV is not a sturdy coat and easily dissociates 
at physiological pH. Therefore, a slightly acidic pH of 6.4 in CCV buffer (see 
section 2.2.1) aids in the isolation of CCV. The synaptosomes were homogenized 
with a ball homogenizer (Isobiotec, Heidelberg, Germany) with a clearance of 12 
µm by 40 passages; the homogenized synaptosomes were transferred to Beckmann 
Eppendorf cups and centrifuged at 25000x g in the ultracentrifuge (Beckman 
Ultramax, Rotor type: TLA55) for 20 minutes. The supernatant was discarded and 
the pellet was resuspended in 550 µl of CCV buffer and the protein concentration 
was determined by Bradford assay (see section 2.5.1. The optimal protein 
concentration should be in the range of 2-3μg/μl, for the isolation of Clathrin-coated 
vesicles (CCVs) on the sucrose gradient.  
The synaptic CCVs were purified on 20-50% continuous sucrose gradient. Fresh 
sucrose solution of 50% and 20% were prepared separately in CCV buffer and were 
chilled on ice prior to use. In SW60 Ti rotor tubes (4 ml), 1.75 ml of ice-cold 50% 
sucrose solution was added followed by 1.75 ml of ice-cold 20% sucrose solution. 
The 20-50% continuous gradient was prepared by using Gradient Station IP, 
Biocomp, Canada. 500µl of synaptosomes extract was added on top of the gradient 
and centrifuged in swing bucket rotor (SW 60 Ti) at 33000 rpm for 1.5 hours at 4ºC. 
The gradient of 4 ml in total was fractionated into 10 fractions of 400µl each, and 
ccv distribution was determined by semi-quantitative western blot analysis using 
anti-CHC antibody.  
 
2.3.4. Immunoisolation of a sub-fraction of synaptic Clathrin Coated Vesicles  
 
CCVs were purified from synaptosomes on the sucrose gradient as described in 
section 2.3.2. A subpopulation of the total CCVs fractions was immunoisolated 
with the help of Hsc70 antibody. Hsc70 is a Clathrin basket disassembly protein, 
which is guided to the Clathrin disassembly site by its co-chaperones, Auxillin 1/2. 
At the basket disassembly site, Hsc70 undergoes ATP-ADP cycle and generates 
pressure from inside the basket thereby, disassembling the Clathrin coat (Sousa et 
al, 2016). However, Hsc70 has additional binding sites on the Clathrin coat, where 
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it binds in a comparably more stable and promiscuously way, if not guided to its 
basket disassembly site (Sousa et al, 2016). So, if there would be a different 
association of Hsc70 to the Clathrin basket, then it would be possible to isolate 
those CCVs with anti-Hsc70 mouse monoclonal antibody (Synaptic Systems, 
Göttingen, Germany) and Protein G Sepharose 4 Fast Flow beads (GE Healthcare, 
Uppsala, Sweden). Protein G Sepharose beads bind to the Fc region of Hsc70 
antibody and enable the isolation of antibody bound proteins. 
 
Pre-clearing of CCV fractions (optional)  
 
Protein G Sepharose beads are suspended in 20% ethanol for preservation which 
needs to be removed before the experiment. 50 µl of Protein G slurry was washed 
three times with CCV buffer (see section 2.1.1) to remove ethanol from the beads 
slurry. The washed beads were added to the pooled CCV fractions 6-9, with peak 
fraction of either 7 or 8 (refer section 2.3.3 for CCV preparation) and incubated at 
4ºC for 1 hour on end over end wheel. The beads were spun down at 2000 rpm for 
30 seconds; the supernatant was used for immunoisolation of the sub-population of 
the CCV and beads were discarded. 
The CCV fractions with/without pre-
clearing (fraction 6-9 with peak fraction of either 7 or 8) were incubated with 5 µg 
of anti-Hsc70 antibody on end-over-end wheel at 4ºC, overnight. 60 µl of Protein 
G Sepharose beads were washed three times with CCV buffer and added to the anti-
Hsc70 conjugated CCV fraction, incubated for 3 hours or overnight at 4ºC on end-
over end-wheel. The beads were isolated by centrifugation at 2000 rpm for 30 
seconds and were washed five times with CCV buffer. 60 µl of 3x SDS loading 
buffer (see section 2.2.2.4) was added to the beads, mixed and incubated at 90ºC 
for 5 minutes; the beads were spun down at 2000 rpm 30 seconds and the 
supernatant was isolated as Elution 1; likewise, Elution 2 was isolated. Elution 1, 
Elution 2 and the beads were loaded on Poly-acrylamide gel and analyzed by semi-
quantitative western blot as described in section 2.5.2. 
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2.3.5 Isolation of proteins from adipose tissue 
 
The wild-type and knockout adipose tissue were isolated and flash froze in liquid 
Nitrogen   (-196ºC) and stored at - 80ºC until the experiment. The knockout and 
wild-type adipose tissue preparations were always done in parallel on the same day 
to take into account any differences based on sample preparation. On the day of the 
experiment, adipose tissue was thawed on ice and sliced with a scalpel in 1.5 ml of 
PBS buffer with proteinase inhibitor cocktail. The sliced cortex was transferred to 
a glass porter and was homogenized with "Loose Piston" until no visible pieces of 
tissue sample were observed, followed by "tight Piston" until reduced resistance 
was felt. The homogenized adipose tissues were centrifuged at 1000x g for 10 
minutes; the supernatant was transferred to a new Eppendorf with a 22G needle. It 
is important to take the supernatant carefully, by avoiding the fat layer accumulated 
at the top. Pass the supernatant with a 22G needle, 10-15 times; centrifuge at 3300x 
g for 10 min. The supernatant was isolated and the pellet was discarded. The protein 
concentrations of the extracts were determined by Bradford Assay (see section 
2.5.1) and were biochemically characterized by semi-quantitative western blot 
analysis (see section 2.5.2). 
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2. 4. Mouse Embryonic Fibroblast Cells Culture 
 
Mouse embryonic fibroblasts (MEFs) cell lines derived from isogenic wildtype and 
σ1B-/-, μ1A-/- mice were used.  
 
MEF Cell lines  Description References 
 S1B111 D5 MEF σ1B +/+ (Glyvuk et al, 2010) 
S1B111 E8 MEF σ1B -/- (Glyvuk et al, 2010) 
24A MEF μ1A -/- :: μ1A cDNA (Meyer et al, 2000) 
24 MEF μ1A -/- (Meyer et al, 2000) 
 
 
2.4.1. Thawing of the MEF cells: 
 
MEF cells were stored in liquid Nitrogen for long-term storage as described in 
section 2.4.4. The frozen cells were taken out of liquid nitrogen and the vials were 
thawed in 70% ethanol at 37ºC to get rid of any contaminants on the vials.  Thawed 
cells were cultured and maintained by passaging as described in section 2.4.2 and 
2.4.3. 
 
 
2.4.2. Culturing of the MEF cells: 
 
Frozen cells were thawed as described in section 2.4.1. The cells were preserved in 
freezing media for long-term storage, and in order to remove the freezing media, 
10 ml of pre-warmed DMEM growth media (see section 2.2.4.3) was added to the 
thawed cells and centrifuged at 300x g for 10 minutes. The supernatant was 
removed and the pellet containing the cells were resuspended in 5 ml of fresh 
DMEM media and were seeded on the sterile tissue culture flask (25 cm2); 
additional 10 ml of fresh media was added in the flask and incubated under water 
saturation atmosphere at 37ºC and 5% (v/v) CO2. The MEF cells are adherent cells 
and grow at the bottom of the flask. The growth and adherence of the cells were 
checked after two hours. The cells were allowed to grow until confluent (2-3 days). 
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2.4.3. Maintenance of the MEF cells culture 
 
The cells were grown until confluent as described in section 2.4.2 and were 
passaged after the culture flask becomes confluent. The cell culture media from the 
confluent plates were removed and the cells were washed with PBS three times. 0.5 
ml of Trypsin-EDTA (see section 2.2.4.2) was added and incubated for 5 minutes 
at 37ºC, to detach the adherent cells growing on the bottom of the flask. 4.5 ml of 
fresh pre-warmed DMEM media was added to resuspend the cells. 500 µl of the 
resuspended cells were added to the new tissue culture flask with 4.5 ml of DMEM 
media to have a split ratio of 1:10. The cells were incubated at 37ºC and 5% (v/v) 
CO2 until confluent. 
 
2.4.4. Long-term storage of MEF cells 
 
For long-term storage, the cells were stored in liquid Nitrogen (-196ºC). For this 
purpose, the cells were grown until confluent and detached from the bottom of the 
flask as described in section 2.4.3. The cells were centrifuged at 300x g for 5 
minutes at room temperature; supernatant was removed and the pellet was 
resuspended in 1 ml of freezing media (see section 2.2.4.4) containing dimethyl 
sulfoxide (DMSO). DMSO in the freezing media is used to avoid the formation of 
ice crystals when freezing the cells in liquid Nitrogen. Aliquots of 250 µl were 
prepared in 1 ml cryotubes, stored at -20ºC for three hours, and eventually moved 
to liquid Nitrogen.  
 
2.4.5. Protein extraction from MEF cells: 
 
MEF cells were grown until confluent as described in section 2.4.2. The confluent 
cells were washed with PBS three times. 1 ml of PBS was added and the cells were 
scrapped with a cells scraper and were added to 2 ml eppendorf tubes. The cells 
were centrifuged at 200x g for 10 minutes; supernatant was removed and the pellet 
was washed with lysing buffer (PBS pH 7.4, Proteinase Inhibitor Cocktail, Sigma, 
St. Louis, USA) and centrifuged at 200x g for 5 minutes at 4ºC. The supernatant 
was removed and the pellet was resuspended in 2 ml of fresh lysing buffer and 
homogenized by passing the suspension through a 22G needle. The protein 
   59 
concentrations were determined by Bradford assay (section 2.5.1) and were further 
analyzed by semi-quantitative western blot (section 2.5.2). 
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2.5. Biochemical analysis of protein extracts: 
 
2.5.1. Protein concentration determination by Bradford Assay: 
 
Bradford Assay was used to determine the total protein concentrations in the tissue 
and in the cell lysates. 200μl of 5x Bradford reagent (Bio-Rad, Germany) was 
mixed with 800μl of water in an eppendorf tube, and 4μl of protein sample was 
added to the mixture. The reaction mixture was incubated for 5 minutes, transferred 
to UV spectroscopy cuvette and absorbance was measured at 595 nm. Bradford 
reagent (1x) without protein sample served as blank. The protein concentration of 
the samples was calculated from the BSA standard reference curve generated by 
measuring the known concentrations of BSA (Bovine serum albumin). BSA 
standard curve was made by measuring BSA (1mg/ml) in the range of 2-16 μg at 
595 nm.  
 
2.5.2. Semi-quantitative western blot analysis: 
 
2.5.2.1. SDS Poly-Acrylamide Gel Electrophoresis: 
 
Sodium Dodecyl Sulfate Polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to the standard protocol established by (Laemmli, 1970). SDS-
PAGE is a commonly used biochemical method to separate proteins according to 
their molecular mass: by the differential rate of migration of proteins through the 
matrix (polyacrylamide gel). This method is based on the principle that a charged 
molecule moves towards its opposite charge electrode under a constant electric 
field. Sodium Dodecyl Sulfate (SDS) is an amphipathic surfactant molecule with 
an anionic head group and a 12carbon tail attached to the anionic head group. SDS 
denatures and linearizes the proteins by binding to the amino acid chain with its 
hydrocarbon tail. The SDS imparts an overall negative charge to the proteins so that 
the migration is based upon their size and not on their charge. The protein samples 
were also boiled in the presence of reducing agents as DTT (dithiothreitol) or BME 
(2β-mercaptoethanol), which further reduces disulfide bonds in the proteins tertiary 
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structure and linearize, the proteins (see section 2.2.2 for the composition of buffers 
and solutions used.) 
The matrix for the separation of proteins was made of polyacrylamide 
(acrylamide/bisacrylamide) as it is inert in nature and could be easily made at 
different concentrations for variable pore size. The polymerization of 
acrylamide/bisacrylamide takes place by free radical mechanism initiated by 
Ammonium peroxodisulfate (APS) in the presence of N,N,N′,N′- 
Tetramethylethylene-1,2-diamine (TEMED). Tris-HCl buffer was used for pH 
adjustment. The polyacrylamide gel was prepared in between two glass plates. The 
dimensions of the gel were 55 mm x 85 mm. The gel was divided into two parts, 
upper "stacking gel" and the lower one "running gel". The stacking gel has a low 
concentration of acrylamide/bisacrylamide and low pH of 6.8. The running gel has 
pH of 8.8 and acrylamide concentration ranging from 5% to 12.5% depending upon 
the size of the proteins to be separated (10% is optimum for proteins ranging from 
100kDa to 25kDa). The running gel is prepared first and poured between the glass 
plates; covered with ethanol to avoid the contact with oxygen for the polymerization 
of the gel. Polymerization takes approximately 15-20 minutes. After the running 
gel has polymerized completely, ethanol was removed and stacking gel was poured 
and the comb was inserted. The polyacrylamide gel was run in glycine buffer with 
pH 8.3.  
Protein samples (40 μl) were mixed with 8μl of with 6x reducing buffer (see section 
2.1.2) and fresh DTT (50 mM) and boiled at 95°C for 5 minutes. After the protein 
samples reached room temperature, it was loaded in the gel pockets along with the 
standard protein ladder of known molecular weight for reference. A constant 
current of 15 mA was applied until the protein sample reached running gel part; 
subsequently, the current was increased to 30 mA and the gel was allowed to run 
till the samples reach the end of the running gel (around 50-60 minutes).  
 
 
 
 
 
 
2.5.2.2. Semi-dry western blot: 
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The proteins were separated by SDS-PAGE as described in section 2.5.2. The 
separated proteins were transferred from the gel to a support membrane made of 
nitrocellulose (Amersham Protran 0.45 micron, GE Healthcare, Germany) for 
further analysis by Immunostaining. A transfer sandwich was prepared as shown in 
Fig. 2.1 to transfer the proteins from the gel to the membrane. Transfer sandwich 
consisted of three filter papers (Filter paper 330 g/m2, Sartorius Stedim Biotech 
GmbH, Göttingen), nitrocellulose membrane and polyacrylamide gel without 
stacking part, soaked in anode buffer (see section 2.1.3) and three filter papers 
soaked in cathode buffer (see section 2.1.3). The transfer of the proteins was done 
at a constant electric field of 1mA/mm2 (dimensions of the gel 55 mm x 85 mm) 
for 30 minutes to 120 minutes depending upon the size of the proteins to be 
transferred. The proteins with molecular mass of 20-25 kDa required 30 minutes of 
transfer time while 200-250 kDa proteins required 120 minutes.  
 
 
Figure 1.2 Semi-dry western blot transfer sandwich: The transfer sandwich was assembled as 
shown. The flow of proteins takes from cathode to anode as the proteins extracted are negatively 
charged imparted by SDS. (Figure adapted from GE healthcare website) 
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2.5.2.3. Immunostaining of proteins bound to the nitrocellulose membrane 
 
The proteins in the tissue/cell extracts were separated and transferred to the 
nitrocellulose membrane as described in section 2.5.2.1 and 2.5.2.2, respectively. 
The proteins on the membrane were detected by specific primary antibody followed 
by an appropriate secondary antibody. The membrane was incubated in blocking 
solution (5% skimmed milk in TBST) for 1 hour at room temperature with gentle 
shaking. Primary antibody was diluted to the desired concentration in blocking 
solution and the membrane was incubated overnight at 4ºC with gentle shaking. 
Primary antibody was removed and can be reused for up to 6-8 times; the membrane 
was washed with blocking solution, three times 10-15 minutes each and incubated 
with appropriate HRP (Horse Radish Peroxide) coupled secondary antibody in 
blocking solution (1:10000) for 1 hour at room temperature with gentle shaking. 
The secondary antibody was removed; the membrane was washed with TBST (see 
section 2.1.3), three times for 10-15 minutes. The membrane was incubated in 
chemiluminescent substrate solution (see section 2.1.3) for 5 minutes and imaged 
by Intelligent Dark Box II camera (Fuji Film, Japan) 
 
2.5.2.4. Stripping of nitrocellulose membrane 
 
The proteins on the nitrocellulose membrane were detected by immunostaining as 
described in section 2.5.2.3. The membrane was reused for probing with different 
antibodies by removing the primary and secondary antibody under the mild 
condition to minimize any loss of proteins. The membrane was incubated in 
Glycine stripping buffer, pH 2 (glycine, SDS, tween 20, see section 2.2.3.7) for 10 
minutes at room temperature with gentle shaking; washed with PBS (see section 
2.1.3) twice for 10 minutes followed by washing with TBST twice for 10 minutes. 
The membrane was then ready for Immunostaining as described in section 2.5.2.3. 
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2.5.2.5 Primary antibodies 
 
 
Antibody  Epitope Species Source Dilution 
Amphiphysin  aa 2-15 Rabbit  Synaptic System 1:1000  
Arf6  peptide aa 150 C-
ter  
Rabbit Abcam 77581 1:1000 
Endophilin A1 mouse aa 256-276 Rabbit SYSY 159 002 1:1000 
Git 1 Rat aa 375-770 C-
ter 
Mouse Acris AM60013 
PU-N 
1:1000 
Hsc70 aa 391-546 Mouse  SYSY 149 011  1:1000 
Hsp110 Haster aa703-858 Mouse BD 610510 1:1000 
Hsp90 α Human peptide  Rabbit Bioss bs-10100R  1:100 
Intersectin-1 mouse aa 800-909 Mouse  BD 611574 1:500 
LRRK2 Human aa 2500-
2527 
Rabbit  NB300-268 1:1000 
SGIP1 human aa 1-30  Rabbit Acris 
AP53888PU-N 
1:500 
Synaptojanin-1 
splice variant 
aa 1140-1155 Rabbit SySy 145 103 1:1000 
Synaptojanin-1 
ubiquitous 
aa 1292-1308 C-
term 
Rabbit SySy 145 103 1:1000 
α-adaptin aa 38-255 Mouse BD 610502 1:2000  
γ1-adaptin BD  
 
C-term/ear-domain Mouse BD 610386 1:2000  
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Chapter 3: Results  
 
 
3.1 Altered AP1 and AP2 mediated protein transport in σ1B-/- synapses 
 
The AP1/σ1B-/- mice are hypoactive and have defects in motor coordination and 
have impaired spatial learning and memory (Glyvuk et al, 2010) (As described in 
section 1.3.2). Since the hippocampus is the site of learning and memory formation, 
the hippocampal synapses from wild-type and knockout mice were analyzed by 
electron microscopy to study the underlying neurological changes (Glyvuk et al, 
2010). This analysis of hippocampal synapses has revealed that σ1B knockout mice 
have a slower synaptic vesicle-recycling rate than the wild-type mice. Moreover, 
the synaptic vesicle recycling is incomplete and only 70% of the synaptic vesicles 
are reformed. Surprisingly, σ1B-/- synapses have an accumulation of endosomes 
and clathrin-coated vesicles (CCVs) in the synapses, which was not as expected, 
given the slower rate of synaptic vesicle recycling and fewer synaptic vesicles in 
the σ1B-/- synapses. Accordingly, one would expect also fewer CCVs mediating 
endocytosis (Glyvuk et al, 2010) (See section 1.3.2 for details). Subsequently, a 
protocol for the isolation of the accumulated endosomes was developed and they 
were biochemically characterized. The accumulated endosomes were PI3P positive 
early endosomes and not the ‘bulk endosomes’ generated by the endocytosis of the 
large plasma membrane domains. The early endosomes sort proteins into different 
endocytic routes, and of all the possible exit routes for proteins out of early 
endosomes, only the multivesicular body endosome (MVB), endolysosomal 
degradation pathway is up-regulated, possibly degrading almost about one-third of 
the synaptic vesicle proteins (Kratzke et al, 2014).  In the brain, two isoforms of the 
AP1 complex are being expressed: one with the brain-specific σ1B subunit 
(AP1/σ1B) and another with the ubiquitous σ1A isoform (AP1/σ1A). In the absence 
of AP1/σ1B complex, the AP1/σ1A forms a complex with ArfGAP1 and Rabex5 
on these early endosomes and enhances their maturation into multivesicular late 
endosomes via the Rab5/Vps34 pathway (Candiello et al, 2016) (see section 1.3.4, 
for detailed molecular mechanism).  
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In order to study the molecular details for the accumulation of CCVs, synaptic 
CCVs were isolated on a sucrose gradient and were biochemically characterized. 
The sample preparations from the brain were critical for the analysis, and few 
important steps were always taken care of. The synapses and CCVs fractions were 
prepared from wild-type and σ1B-/- mice brains, always in parallel. It was 
important that the brains were isolated in the late afternoon only after the mice 
facility staffs leave, so that the nocturnal animals have some time to relax and thus 
should have comparable neuronal activities. The biochemical characterizations 
were done by semi-quantitative western-blot analysis, and the protein levels of 
knockout samples were compared to the wild-type (wild-type =100%) samples 
prepared on the same day in parallel. More than one protein was detected on one 
western-blot membrane in order to have internal controls for the loaded protein 
amounts. The data from at least three biologically independent samples were 
analyzed and plotted as a box-plot diagram to represent the complete set of data and 
a statistical analysis, as the box-plot also represents the median of the complete data 
set. 
  
3.1.1 AP2 CCV accumulation in the AP1/σ1B-/- synapses 
 
The biochemical characterization of the accumulated CCV in the σ1B-/- synapses 
revealed that they were not non-functional AP1 CCV, as one would expect due to 
the one missing subunit of an AP1 complex, but they were AP2 CCV. The amount 
of AP2 CCV in the synapse is almost doubled in the σ1B-/- synapses compared to 
wild-type synapses. However, the amount of AP1 CCV is reduced in the σ1B-/- 
synapses compared to wild-type (Kratzke et al, 2014). This increase in the AP2 
CCV was not expected given the slower synaptic vesicle recycling rate and less 
synaptic vesicles in the σ1B-/- synapses. During normal stimulation, AP2 CCVs are 
formed at the pre-synaptic plasma membrane, whereas, in the case of high 
stimulations, synaptic vesicle are endocytosed by fast endocytosis, in which plasma 
membrane is first internalized by actin-mediated endocytosis to form plasma 
membrane vacuoles, and then AP2 forms CCV from those vacuoles (Soykan et al, 
2016), (Soykan et al, 2017), (González-Gaitán & Jäckle, 1997). Thus, the reduced 
synaptic vesicle-recycling rate in the σ1B knockout synapse does not explain the 
accumulation of AP2 CCV. The increase in AP2 CCV could be due either due to 
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an increase in clathrin-mediated endocytosis of non-synaptic vesicle proteins like 
scaffolding proteins, ion channels or receptors, or due to the slow uncoating of the 
AP2 CCV coat and thus an extended lifetime, leading to the accumulation of AP2 
CCV. However, these two possibilities are not exclusive of each other and could 
operate in parallel. On the other hand, it is not clear whether this accumulation of 
AP2 CCV is specific for the synapse or whether it is a general phenotype of σ1B 
deficiency. 
 
3.1.2. AP2 CCV accumulation is synapse specific in AP1/σ1B-/- mice 
 
Besides the neuronal phenotype, adipose tissues in AP1/σ1B-/- mice also have a 
lipodystrophy (Baltes et al, 2014). The AP1/σ1B-/- mice weigh less than the wild-
type mice and have comparative lower adipose tissue volumes in the body. The 
biochemical characterization of the adipocytes revealed that they overexpress 
sortilin. In the 3T3L1 adipocyte model cell line, over-expression of sortilin is 
sufficient to suppress adipogenesis (Baltes et al, 2014). Sortilin is a neurotrophin 
binding-receptor and it is enriched in the glucose transporter GLUT4 storage 
vesicles in adipocytes (Lin et al, 1997; Morris et al, 1998). In the σ1B-/- adipocyte 
cells, the GLUT4 expression, and serum glucose homeostasis was normal despite 
the over-expression of sortilin, which suggests the existence of adipocyte-specific, 
GLUT4 independent functions of sortilin in the adipocyte cells.  
 
The σ1B-/- binding of sortilin is mediated by a specific binding motif on sortilin, 
which is not bound by σ1A. The deficiency of σ1B does not completely block the 
transport of sortilin out of an organelle, rather its transport to the lysosomes is 
reduced (Baltes et al, 2014). Sortilin binds DLK1 receptors, an inhibitor of late-
stage adipocyte differentiation. In the σ1B deficient mice adipocyte cells, sortilin is 
over-expressed and this over-expression of sortilin prevents the down-regulation of 
DLK1, leading to the enhanced inhibition of adipocyte differentiation (Baltes et al, 
2014). The brain is the tissue with the highest expression of σ1B and sortilin. 
However, the sortilin is not overexpressed in the σ1B-/- brain, suggesting that 
adipocyte-specific σ1B dependent routes exist for the transport of sortilin (Baltes et 
al, 2014).  
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In the brain of σ1B-/- mice, we have observed an accumulation of AP2 CCV, 
despite the slow synaptic vesicle-recycling rate and fewer synaptic vesicles. In 
order to understand, whether this phenotype is specific to the brain, I have analyzed 
the adipocyte cells from wt and σ1B-/- mice for the expression of AP1 and AP2 
(Figure 3.1). The adipocytes from wild-type and σ1B-/- mice were isolated and 
analyzed for AP1 and AP2 expression levels by semi-quantitative western-blot 
analysis. The AP1 expression levels in these adipocytes were slightly increased by 
20% and the AP2 level was also increased by 10%, but not doubled as in case of 
the synapses. In the synapse, we have an increase to 170% of wild-type levels in 
AP2 (Kratzke et al, 2014). However, I could not isolate CCVs from these 
adipocytes, as the adipocytes have comparatively less amount of proteins with 
respect to their volume, thus making it difficult to isolate enough CCVs on sucrose 
gradient from the adipocytes (data not shown). Thus, the accumulation of AP2 CCV 
in the synapse of the σ1B-/- mice is a brain-specific transport route mediated by 
AP1 and AP2 CCVs and not a general phenotype pertaining to the deficiency of 
AP1/σ1B. 
 
3.2. Existence of stabilized AP2 CCV in σ1B-/- synapses  
 
B
3 3
WT   KO
AP-1 (ϒ1)
AP-2 (α)
A B
Figure 3.1 (A) Comparison of the levels of the all AP1 complexes by detecting AP1/γ1 and all AP2 complexes 
by detecting AP2/α in the adipocytes of wild-type (wt=100%) and σ1B-/- mice. The numbers in the box represent 
the number of biological independent samples analyzed. (B) Representative semi-quantitative western-blots of 
the analysis AP1 and AP2 comparison done in A.. This result is published, hence figure adapted and modified 
from (Zizioli et al, 2017) 
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AP2 CCV accumulates in the σ1B-/- synapses as described in section 3.1.1. The 
accumulation could be either due to an increase in clathrin-mediated endocytosis 
(CME) of non-synaptic vesicle proteins like scaffolding proteins, ion channels or 
receptors, or it could be due to the slow uncoating of the AP2 CCV coat and thus 
an extended lifetime of the CCV, leading to their accumulation. If the accumulated 
AP2 CCVs have a stable coat and thus have an extended lifetime, then the question 
was how to identify and isolate these stablilized AP2 CCV?  
As described in section 1.1.2.3, during a CCV cycle, when a CCV is formed at the 
donor membrane, it detaches from the donor membrane and before its fusion with 
the target membrane to deliver its cargo proteins, the CCV has to shed off its 
clathrin coat. Hsc70 and its co-chaperones, Auxilin 1 and 2 mediate the disassembly 
of the clathrin basket (Braell, 1984; Schlossman, 1984; Scheele et al, 2003). Auxilin 
1/2 recruit Hsc70 to the basket disassembly site, where it starts the disassembly 
process (Scheele et al, 2003)(see section 1.1.2.3.2 for detailed molecular 
mechanism of clathrin uncoating process). However, Hsc70 has additional binding 
sites on the clathrin basket of a CCV, where it binds more stably and promiscuously, 
if not guided to the disassembly site (Xing et al, 2009; Park et al, 2015; Sousa & 
Lafer, 2015). Based on this differential, but stable mode of binding of Hsc70 to the 
CCV, we reasoned that, if there is a stable pool of AP2 CCV, then it could be 
immunoisolated by anti-Hsc70 monoclonal antibodies.  
 
In our recent study (Candiello et al, 2017), we have immunoisolated a sub-pool of 
AP2 CCV from wild-type and σ1B-/- synapses, by pull-down with anti-Hsc70 
antibody. The biochemical characterization of this immunoisolated pool suggests 
that, σ1B-/- synapses contain twice the amount of these AP2 CCV, than the 
comparable pool of wild-type synapses. This increase in AP2 is similar to the 
increased amounts of AP2 in the total accumulated CCV pool (Kratzke et al, 2014), 
thus representing a sub-population of the accumulated AP2 CCV pool. In addition, 
it was observed that σ1B-/- synapses have normal amounts of Hsc70, but in the total 
accumulated CCV pool, there was also a 100% increase in the levels of Hsc70 
associated with these CCV (Kratzke et al, 2014). This increased level of Hsc70 
suggests, that the majority of AP2 CCV in the total accumulated CCV pool were 
undergoing rapid uncoating similar to the wild-type CCV. Thus the increase in AP2 
CCV could be solely due to enhanced clathrin-mediated endocytosis, despite the 
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reduction in synaptic vesicle number and synaptic vesicle recycling rate (Kratzke 
et al, 2014). In the Hsc70 immunoisolated AP2 CCV, we have observed an increase 
in the levels of Auxilin 1/2, but the levels of Hsc70 was not increased, suggesting 
that Hsc70 is not guided to the clathrin basket disassembly site, where it starts the 
disassembly process of the clathrin basket (Candiello et al, 2017). Thus, the levels 
of Hsc70 and of Auxilin 1/2 demonstrate that these immunoisolated CCV have a 
stabilized CCV coat and thus have an extended lifetime. We have also observed an 
increase in Clathrin-heavy-chain (CHC), and the level of Clathrin-light-chain 
(CLC) is almost doubled (Candiello et al, 2017). CLC binds to the proximal legs of 
CHC and is required for the stability and lifetime of the clathrin basket (Brodsky, 
2012), further supporting the enhanced stability of the immunoisolated AP2 CCV. 
 
 
3.2.1 Upregulated CME in the stabilized AP2 CCV of AP1/ σ1B-/- synapses : 
 
 
The stabilized pool of AP2 CCV should either represent just an intermediate early 
stage of the CCV uncoating reaction or they should be the CCV of a specific 
Clathrin-mediated-endocytosis (CME) route. If the stabilized AP2 CCV represent 
a specific endocytic route in the synapse, then they should be enriched in specific 
cargo proteins. Stonin2 is a co-adaptor of AP2 and has a μ-homology domain, 
which binds to cargo proteins like the C-terminus of AP2/μ2 adaptin.  
We have analyzed the expression and distribution of Stonin2 in σ1B-/- synapses. In 
our previous studies, we have observed that σ1B-/- cortices and synapses have 
∼25% and ∼10% less Stonin2 compared to the wild-type respectively and the total 
synaptic CCV in σ1B-/- synapses contains ∼20% less Stonin2 compared to the 
wild-type (Kratzke et al, 2014). The stabilized AP2 CCV pool of AP1/σ1B-/- 
synapses contains 130% more of Stonin2 than wild-type (Figure 3.2A-D), 
implicating that stabilized AP2 CCV transport preferentially Stonin2 (cargo 
protein). Stonin2 binds Git1 (GPCR kinase-interacting protein) and both localize at 
the active zone. Git1 is a scaffolding protein present at the outer rim of the 
presynaptic active zone, involved in the organization of cytomatrix and presynaptic 
active zone structural proteins. Git1 function is important for synaptic vesicle 
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recycling, but the molecular mechanisms are not known (Podufall et al, 2014). 
Point mutations in Git1 are associated with Schizophrenia. We analyzed the levels 
of Git1 in the synapse, the total synaptic CCV pool, and in the stabilized AP2 CCV 
pool. The Git1 level is decreased in the total CCV by 30%, but the stabilized AP2 
CCV contains 120% more of Git1 than its comparable wild-type AP2 CCV (Figure 
3.2A-D). Thus, the increase in Git1 in the stabilized pool suggests that Git1 is 
redistributed from the active zone in the stabilized AP2 CCV, mediated by Stonin2. 
The level of Git1 is also increased in the synapse of σ1B-/- by 50%, suggesting that 
it is not endocytosed to be degraded, but is maintained and may function in other 
pre-synaptic domains. Git1 is a scaffolding protein with several protein interaction 
domains, with which it takes part in the organization of actin cytoskeleton and 
participates in cell migration and synapse formation. The deficiency in Git1 impairs 
the synaptic vesicle recycling (Podufall et al, 2014), thus the increased level of Git1 
in the stabilized pool could support the synaptic vesicle recycling and could 
partially compensate for the reduction in synaptic vesicle numbers in the σ1B-/- 
mice synapses.  
 
Git1 has an ArfGAP activity and its substrate at the plasma membrane is Arf6. Arf6 
regulates important vesicular transport routes, including CME and synaptic vesicle 
recycling pathways (Tagliatti et al, 2016; Kim et al, 2015). Thus, we analyzed and 
compared the expression levels of Arf6 in the synapses, in the total synaptic CCV 
and in the stabilized AP2 CCV pool. Arf6 levels are decreased in the synapse by 
25%, but in the total and the stabilized pool, Arf6 is increased by 30%. The reduced 
amount of Arf6 in the synapse is not limiting for its recruitment in the total as well 
as in the stabilized AP2 CCV pool. However, Arf6 seems not to be in involved in 
the differential regulation of the two CME pathways.  
This complete set of experiments was done along with my predecessor, Dr. Ermes 
Candiello. He analyzed the Stonin2 data and the stabilized pool data of Git1 and 
Arf6. I have analyzed the cortex, synapse and total CCV data of Git1 and synapse 
total CCV data of Arf6. The stabilized AP2 CCV represents a specific CME route 
was verified and confirmed by a quantitative mass-spectrometric analysis (iTRAQ), 
done by E. Candiello in collaboration with Dr. O Jahn (MPI Experimental 
Medicine, Göttingen) and Dr. B. Schmidt (mass-spectrometry department of our 
institute), published in (Candiello et al, 2017). 
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Figure 3.2. Comparison of the levels and distribution of (A) Stonin2 in the stable pool, isolated from 
wild-type (wt) and knockout (ko) mice brain. (B) Git 1 in synapse, total CCV (∑ CCV) and in the 
stabilized pool (st CCV) isolated from wild-type (wt) and knockout (ko) mice brain (C) Arf6 in 
synapse, total CCV (∑ CCV) and in the stabilized pool (st. CCV) isolated from wild-type (wt) and 
knockout (ko) mice brain. Wild-type level (wt) was set to 100% and the knock-out samples were 
compared with respect to the wt. The numbers in the box plot indicate the number of individual 
biological samples analyzed. (D) Representative western blot of the comparison and analysis done 
for Stonin2, Git1 and Arf6. These results are published, hence figure adapted from (Candiello et al, 
2017). E. Candiello contributed stonin2 data and the stabilized pool data of Git1 and Arf6 and R. 
Mishra contributed cortex, synapse and total CCV data of Git1 and the synapse, total CCV data of 
Arf6.  
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3.3 Molecular mechanisms for the formation of stabilized AP2 CCV: 
 
3.3.1 Reduced recruitment of Hsp110 to the stabilized AP2 CCV: 
 
During the uncoating reaction of a CCV, Hsc70 is recruited by its co-chaperones, 
Auxilin 1/2 and mediates the disassembly of the clathrin basket (see section 1.2.3.2 
for the molecular mechanism of CCV uncoating). However, after the disassembly 
of the clathrin basket, Hsc70:ADP still remains associated with the clathrin triskelia 
and inhibits the polymerization of the clathrin, required for subsequent rounds of 
CCV formation (Schuermann et al, 2008). Therefore, Hsc70 has to be released from 
the Hsc70:ADP:clathrin complex. This is achieved by replacing ADP for ATP in 
the Hsc70:ADP:clathrin complex. Hsc70 nucleotide exchange factors (NEFs) are 
the class of proteins, which regulate the dissociation of Hsc70 from their protein 
substrates, by stimulating the release of ADP from the Hsc70:ADP: substrate 
complex (Packschies et al, 1997). The exchange of ADP for ATP further stimulates 
the release of the substrate from the otherwise stable Hsc70 substrate complex. 
Hsp110 is a member of the Hsc70 family and is the most abundant Hsc70 NEF in 
the vertebrate brain (Morgan et al, 2013). Hsp110 also plays an important role in 
the regulation of synaptic vesicle endocytosis. The inhibition of Hsp110 at the giant 
reticulospinal synapses of sea lamprey shows a defect in synaptic vesicle 
endocytosis. Presumably, the inhibition of Hsp110 blocked its NEF activity, 
thereby inhibiting the release of Hsc70 from clathrin, thus limiting the availability 
of clathrin for subsequent rounds of endocytosis (Morgan et al, 2013).  
 
I have analyzed the levels of Hsp110 in the whole brain cortex, synapses, the total 
synaptic CCV pool, and the immunoisolated stabilized AP2 CCV pool (Figure 
3.3B,C). The amount of Hsp110 is increased in the σ1B-/- whole brain cortex by 
30%, but in the synapses, it is decreased by 60% with respect to the wild-type. 
However, this decrease in the synapses is not limiting the recruitment of Hsp110 in 
the total CCV pool. In the total CCV pool, the amount of Hsp110 is not changed in 
the knockout synapse. However, in the immunoisolated stabilized AP2 CCV pool, 
HSP110 is reduced by 40% in the knockout synapses. The reduced levels of Hsp110 
in the stabilized AP2 CCV suggest, that altered Hsp110 expression could be one of 
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the factors inhibiting the recruitment of Hsc70 to the clathrin basket disassembly 
sites. 
 
Figure 3.3. Hsp110 in the uncoating of CCV:  (A) Molecular mechanism of HSP110 in CCV 
uncoating, during synaptic vesicle (SV) endocytosis: After the SV has fused with the pre-synaptic 
plasma membrane, it releases the neurotransmitters (exocytosis) and SV is endocytosed back for 
second round of exocytosis. During clathrin-mediated endocytosis, when a vesicle is formed, it has 
to shed off its clathrin coat before its fusion to the target membrane. Hsc70 and its cochaperones 
Auxilin1/2 mediate the uncoating process. After disassembly of clathrin basket, Hsc70 is still 
associated with Clathrin triskelia as Clathrin: Hsc70: ADP complex, and requires the nucleotide 
exchange factor (NEF) activity of HSP110 for its dissociating from clathrin triskelia. HSP110 is the 
most abundant NEFs in the brain and the inhibition of HSP110 leads to the defects in uncoating 
mechanisms, leading to the accumulation of CCV in the synapses (Morgan et al, 2013). Model 
adapted from (Sousa & Lafer, 2015) (B) Comparison of the levels and distribution of HSP110 in 
cortex, synapse, in the total CCV (∑ CCV) and in the stabilized AP2 CCV (st CCV) isolated from 
wild-type (wt) and knockout (ko) mice brain (C) Representative western-blots of the HSP110 
comparison done in B.
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3.3.2 Stability of AP2 membrane binding 
 
The reduced recruitment of Hsp110 and of Hsc70, despite the increased amounts of 
its activators, Auxilin1/2 in the immunoisolated AP2 CCV, demonstrates that the 
clathrin baskets of these CCVs are not readily disassembled. The regulation of the 
binding of the AP2 to the membrane also plays an important role in the stability of 
a CCV. The binding of AP2 to the membrane lipid PIP2 and to cargo proteins is 
enhanced by its conformation change from a closed to an open conformation, in 
which the C-terminal domain of AP2/μ2 comes in close contact to the membrane 
and binds firmly to PIP2 and the cargo proteins. This conformational change is 
favored by the phosphorylation of μ2-Thr156 by AP2-associated kinase, AAK1 
(Ricotta et al, 2002; Conner et al, 2003). AAK1 is not the only kinase, which 
phosphorylates μ2, but the others are not yet known. In our recent study, we have 
observed a dramatic increase in μ2 phosphorylation and in AAK1 kinase activity in 
the stabilized AP2 CCV pool (Candiello et al, 2017). This suggests that the 
phosphorylation of μ2 subunit further aids in the stability of these immunoisolated 
AP2 CCVs. AAK1 mediated μ2 phosphorylation has always been discussed 
exclusively for AP2 activation and the initiation of AP2 CCV formation. However, 
our data show that AAK1 function is used to differentially regulate the AP2 CCV 
life-time (Candiello et al, 2017).  
The plasma membrane enriched phospholipid PI-4,5-P2 is not only bound by μ2 , 
but also by the AP2 adaptins α and β2. Thus, PIP2 contributes to the specific binding 
of AP2 to the plasma membrane and it has to be dephosphorylated to allow the 
dissociation of AP2 from the membrane.  
 
3.3.2.1. Reduced Synaptojanin-1 in stabilized AP2 CCV : 
 
AP2 requires PIP2 on the plasma membrane for its stable binding, and the activity 
of PIP2 phosphatases is essential for the release of AP2 from the membrane. 
Synaptojanins are the PIP2 phosphatases, which dephosphorylate PIP2 and thus help 
in the dissociation of AP2 from the membrane (McPherson et al, 1996) (Figure 
3.5A) (see section 1.2.3.2, for the detailed molecular mechanism). There are two 
isoforms of Synaptojanin-1 expressed in the brain: ubiquitous Synaptojanin-1 and 
  76 
the brain-specific Synaptojanin-1 splice variant, has a C-terminal truncation (Perera 
et al, 2006).  
 
We have tested the expression of both the Synaptojanins, in the cortex, synapse, the 
total synaptic CCV, and in the stabilized AP2 CCV in the wild-type and AP1/σ1B-
/- synapses.  The cortices of σ1B-/- mice contain less Synaptojanin-1, but the 
synapse has around 20% more of Synaptojanin-1 than the wild-type, which is in 
line with the high AP2 CCV turnover (Figure 3.5B-C). However, the amount of 
brain-specific Synaptojanin isoform is not changed in the cortices and synapse of 
σ1B-/- mice. In the total synaptic CCV, the amount of Synaptojanin-1 is not 
changed, but the brain-specific Synaptojanin-1 splice variant is reduced by 20% in 
the AP1/σ1B-/- synapses. This could be because, brain-specific splice variant lacks 
AP2 binding site, and thus is recruited at the late stage of CCV formation by binding 
to Endophilin and/or Amphiphysin, suggesting an isoform-specific function of 
Synaptojanin-1 in the regulation of CCV uncoating (Perera et al, 2006). The 
immunoisolated pool of AP2 CCV from AP1/σ1B-/- synapses has 80% less of both 
Synaptojanin-1 (Figure 3.5B-C). The mechanisms responsible for the recruitment 
of synaptojanins are not isoform-specific and thus the isoforms do not contribute to 
the differential stability of the synaptic AP2 CCV. Therefore, reduced 
Synaptojanin-1 recruitment is contributing in the stabilization of AP2 CCV in the 
AP1/σ1B-/- synapses.  
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Figure 3.5. (A) Scheme representing the fusion and uncoating of a clathrin-coated vesicle at the 
synapses, mediated by endophilin and synaptojanins(Milosevic et al, 2011). Endophilin is recruited 
at the late stage of a CCP from which CCV buds off. Endophilin recruits Synaptojanins. 
Synaptojanin-endophilin interaction is critically important for the fission of CCV. Synaptojanins are 
the PIP2 phosphatases, which dephosphorylate PIP2 and thus, help in the release of AP2 from the 
membrane. Figure adapted from (Milosevic et al, 2011) (B) Comparison of the levels and the 
distribution of Synaptojanin-1 ubiquitous and brain-specific splice variant in cortices, synapses, in 
the total synaptic CCV (Σ CCV) and in the stabilized CCV (st CCV, blue boxes), from wt and σ1B 
−/− mice. Wild-type level is set to 100% and the numbers below the box-plot indicate the number 
of individual biological samples analyzed. (C) Representative western blots of the analysis of 
Synaptojanin 1 and Synaptojanin 1 splice variant, as shown in B. The results are published, hence 
figure is adapted from (Candiello et al, 2017).  E. Candiello contributed the stable pool data and R. 
Mishra contributed cortex, synapse, and the total CCV data. 
 
 
C
A
B
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3.3.2.2 Synaptojanin-1 recruiting proteins EndophilinA1 and Amphiphysin 
 
 
In order to identify the mechanism responsible for the reduced recruitment of 
Synaptojanins, we analyzed first the expression levels of two recruiters of 
Synaptojanin-1, Endophilin A1 and Amphiphysin, which also bind to each other. 
Endophilin A1 recruits Synaptojanin-1 by direct interaction (Perera et al, 2006; 
Milosevic et al, 2011). We determined the level of Endophilin A1 in the cortices, 
synapses, the total synaptic CCV, and in the stabilized AP2 CCV of wild-type and 
AP1/σ1B-/- synapses (Figure 3.6A and 3.6C). The level of Endophilin A1 is slightly 
increased by around 10% in cortices and synapses, but in the total synaptic CCV 
pool, it is reduced by 15% in σ1B knockout compared to the wild-type mice. 
However, in the stabilized AP2 CCV of AP1/σ1B-/- synapses, the amount of 
endophilin A1 is not changed compared to the wild-type CCV. Therefore, the 
amount of Endophilin A1 does not explain the reduced levels of Synaptojanin 1 in 
the stabilized AP2 CCV pool.  
 
Another key protein that interacts directly with Synaptojanin-1 is Amphiphysin. 
Amphiphysin is recruited by AP2 (Olesen et al, 2008) and interacts with dynamin 
and the actin cytoskeleton during dynamin-mediated vesicle fission (Yamada et al, 
2009).  The level of Amphiphysin is slightly increased in cortices and synapses, but 
in total synaptic CCV, it is reduced by 35% and in the immunoisolated pool by 
45%. This reduction in the level of amphiphysin is not comparable with the 
reduction in the level of Synaptojanin-1, thus the reduced level of Synaptojanin-1 
is not a consequence of just less amphiphysin. Therefore, these data suggest the 
involvement of other proteins and regulatory mechanisms, which regulate the 
recruitment of Synaptojanin-1 in the stabilized AP2 CCV.  
This experiment was performed along with my predecessor in the lab, Dr. Ermes 
Candiello. He contributed the stable pool data and I have contributed the cortices, 
synapses, and total CCV pool data.  
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Figure 3.6 (A-B) Comparison of the levels and the distribution of Endophilin A1 (A) and 
Amphiphysin (B) in the cortices, synapses, in the total synaptic CCV (Σ CCV) and in the stabilized 
CCV (st CCV, blue boxes), from wt and σ1B −/− mice. Wild-type level is set to 100% and the 
numbers below the box-plot, indicate the number of independent biological samples analyzed. (C) 
Representative western-blots of Endophilin A1 and Amphiphysin comparison shown in A and B. 
The results are published, hence figure is adapted from (Candiello et al, 2017). E. Candiello 
contributed the stable pool data and R. Mishra contributed cortex, synapse, and the total CCV data. 
 
 
 
3.3.2.3 Reduction of Intersectin-1 in stabilized AP2 CCV  
 
Besides Amphiphysin and Endophilin A1, Synaptojanins also bind the CCV protein 
Intersectin-1. Intersectin-1 (ITSN-1) is a multi-domain adaptor protein that interacts 
directly with dynamin, AP2, Stonin-2 and Synaptojanin-1, along with other CCV 
coat proteins, during the CCV cycle (Figure 3.7B) (Evergren et al, 2007; Pechstein 
et al, 2010). Intersectin-1 is highly expressed in neurons and plays a role in clathrin 
mediated synaptic vesicle recycling. Several studies in the past, have demonstrated 
the role of intersectin-1, in the endocytosis and vesicular trafficking of proteins 
(Hunter et al, 2013; Pechstein et al, 2010). The intersectin-1 knockout mice shows 
defects in vesicle trafficking in the brain (Hunter et al, 2013). Intersectin-1 interacts 
directly with clathrin/AP2 during clathrin mediated synaptic vesicle endocytosis 
and the perturbation of intersectin-1-AP2 interaction in lamprey synapses, inhibits 
the synaptic vesicle recycling (Pechstein et al, 2010).  
 
Structurally, Intersectin-1 (Figure 3.7A) consists of two N-terminal Eps15 
homology (EH) domains, a coiled-coil region (CC) and five Src homology3 (SH3) 
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domains (Wong et al, 2012; O'Bryan, 2010). There are two isoforms of Intersectin 
expressed in mammals: One is the shorter isoform of Intersectin (ITSN-S) and 
another longer isoform of Intersectin (ITSN-L). ITSN-S posses two EH domain, 
one CC domain and five SH3 domains, whereas ITSN-L has additional C-terminal 
domain containing Dbl homology (DH) domain, a pleckstrin homology (PH) 
domain, and a C2 domain (O'Bryan, 2010) (see Figure 3.7A). ITSN1 is expressed 
in brain. The DH-PH domain have GEF activity directly activating Cdc42 
(O'Bryan, 2010). SH3 A-B linker domain of intersectin-1 bind with AP2 α- and β-
appendage domains, and this binding inhibits the binding of synaptojanin-1 with 
intersectin-1 (Pechstein et al, 2010; 2015).  
 
Therefore, in order to understand the differential regulation of the two-endocytic 
pathways, I investigated the expression and distribution of intersectin-1 in the 
cortices, synapses, the total synaptic CCV and in the stabilized AP2 CCV of wt and 
AP1/σ1B-/- synapses. The level of intersectin-1 is slightly reduced in the cortices 
and synapses of the σ1B-/- mice (Figure 3.7C-D). However, the reduced level of 
intersectin-1 in the cortices and synapses does not limit its recruitment in the total 
synaptic CCV pool of AP1/σ1B-/- synapses. The level of Intersectin-1 is increased 
by 100% in the total CCV, again in line with the increase in the levels of AP2 in 
the total CCV. However, in the immunoisolated stabilized AP2 CCV, the level of 
intersectin-1 is reduced by ∼30%, despite the 100% increase in the amount of AP2 
CCV. This selective reduction of Intersectin-1 only in the stabilized AP2 CCV pool 
and not in the total CCV pool of AP1/σ1B-/- synapses, suggests that Intersectin-1 
is involved in the differential regulation of the CCV stability. 
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Figure 3.7 (A) Cartoon representation of the structure of Intersectin-1 long isoform, figure adapted 
from (Wong et al, 2012). (B) Scheme showing molecular interaction of Intersectin 1 with proteins 
involved in the formation of a CCV (C) Comparison of the levels and the distribution of Intersectin-
1 in cortices, synapses, in the total synaptic CCV (Σ CCV) and in the stabilized CCV (st CCV, blue 
boxes), from wild-type (wt) and σ1B −/− mice. Wild-type level is set to 100% and the numbers 
below the box-plot, indicate the number of independent biological samples analyzed. (D) 
Representative western-blots of the analysis of the distribution of Intersectin-1, done in C.  
 
 
  
3.3.2.4 Increased level of SGIP1 in the stabilized AP2 CCV 
 
The selective reduction in the level of Intersectin-1 in the stabilized AP2 CCV pool 
suggests its involvement in the differential regulation of the stable pool formation. 
SGIP1 (Src homology 3-domain growth factor receptor-bound 2-like (endophilin) 
interacting protein 1) is a BAR domain protein, which senses low curvature 
membrane and binds at the early stages of the budding reactions. SGIP1 interacts 
directly with endophilin and membrane phospholipids, during endocytosis at the 
plasma membrane. It was shown that SGIP1 binds to phosphatidylserine and 
phosphoinositides on the plasma membrane and deforms the membrane into narrow 
tubules, suggesting its functions in vesicle formation during endocytosis (Uezu et 
al, 2007). Furthermore, it was also demonstrated that SGIP1 interacts with Eps15, 
a co-adaptor protein of CCV and AP2 (Uezu et al, 2007). SGIP1 also interacts with 
Intersectin-1 during Clathrin-Coated Pit formation. Thus, the determination of 
SGIP1 levels was essential to understand the molecular mechanism for less 
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recruitment of intersectin-1 to stabilized AP2 CCV.  
I have analyzed and compared the expression of SGIP1 in the wild-type and σ1B-
/- mice (Figure 3.5). The amount of SGIP1 is not changed much (∼10%) in the 
cortices and synapses of the AP1/σ1B-/- synapses. In the total CCV, as well as in 
the stabilized AP2 CCV, the amount of SGIP1 is increased by ∼120%, in line with 
the increase in AP2. Since SGIP1 is recruited at early stages of vesicle formation 
and speeds up the budding process, both CME pathways appears to form CCV with 
the same speed. 
The selective reduction of Synaptojanin-1 appears not to be simply due to 
stoichiometric alterations in CCV coat proteins and thus, points towards regulatory 
mechanism involving specific kinases and phosphatases, which regulate the 
formation of the stabilized AP2 CCV in AP1/σ1B-/- synapses. 
 
Figure 3.8 (A) Scheme showing molecular interaction of SGIP1 with other CCV coat proteins 
involved in the formation of clathrin-coated vesicles (B) Comparison of the expression and the 
distribution of SGIP 1 in cortices, synapses, total synaptic CCV (Σ CCV) and immunoisolated stable 
CCV (st CCV, blue boxes), from wild-type (wt) and σ1B −/− mice, (wt=100%). The numbers below 
the box-plot indicate the number of biological samples analyzed (C) Representative western-blots 
of the expression and distribution of SGIP, done in B. 
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3.4. Regulation of stabilized AP2 CCV formation in AP1/σ1B-/-synapses: 
 
3.4.1. Increased LRRK2 in the stabilized AP2 CCV of AP1/σ1B-/- synapses 
 
LRRK2 (leucine-rich repeat kinase 2) is one of the highly expressed kinases in the 
brain and has been shown to be associated with CCV (Arranz et al, 2015), (Paisán-
Ruı́z et al, 2004; Pan et al, 2017) . LRRK2 plays an essential role in brain function 
due to its involvement in synaptic vesicle endocytosis (Arranz et al, 2015). 
Mutations in the LRRK2 kinase are associated with Parkinson’s disease, more 
likely due to the phosphorylation of numerous Rab proteins (Paisán-Ruı́z et al, 
2004). A study done in Drosophila melanogaster suggests, that LRRK2 kinase 
activity is a part of endoA1 (endophilin A1, also known as SH3GL2) 
phosphorylation cycle, which facilitates the efficient formation of synaptic vesicles 
(Matta et al, 2012) at the neuromuscular junction (NMJ). In the mammalian 
synapse, the knockout or the pharmacological inhibition of LRRK2, also exhibit 
defects in synaptic vesicle endocytosis and impairs neurotransmission (Arranz et 
al, 2015). This study also shows that the mammalian BAR domain of endophilin 
A1 is phosphorylated by LRRK2 at residues Thr73 and Ser75 and this 
phosphorylation in the BAR domain inhibits membrane tubulation in-vitro (Arranz 
et al, 2015). LRRK2 also interacts directly with Synaptojanins and it was shown in-
vitro, that LRRK2 phosphorylates Synaptojanin-1, leading to the disruption of 
Synaptojani1-Endophilin A1 interaction during synaptic vesicle endocytosis (Pan 
et al, 2017). Thus, the LRRK2 kinase activity has an important role in the regulation 
of synaptic vesicle endocytosis and could explain the regulatory mechanism for the 
reduced recruitment of synaptojanin-1 and the formation of the stabilized AP2 CCV 
pool.  
 
The LRRK2 level was increased by 60% in the cortices, whereas it is reduced by 
40% in the synapses of AP1/σ1B-/-, compared to wild-type mice (Figure 3.9B,C). 
However, in the total synaptic CCV pool and in the stabilized AP2 CCV, the level 
of LRRK2 is increased by ∼20%. The increase in LRRK2 level in both total and 
the stabilized AP2 CCV suggest that LRRK2 may not be involved in the differential 
regulation of the two CME pathways. However, LRRK2 is a large protein of 2527 
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amino acids (Figure 3.9A), with multiple protein interaction domains apart from its 
kinase activity domain, thus it interacts and regulates the levels of several different 
proteins and participates in a number of signaling pathways. The predicted LRRK2 
domain structure (Figure 3.9A), suggests that LRRK2 is composed of 13 LRRs 
domains, which play roles in protein-protein interaction, followed by the Roc, a 
GTPase domain which regulates the activity of kinase domain, COR domain which 
is LRRK2 dimerization domain and MAPKKK domain, a kinase domain 
functioning in mitogen-activated protein kinase signaling pathways, as well as 
seven WD40 at the C-terminus responsible for protein-protein interaction (Gandhi 
et al, 2009). 
 
Therefore, despite the comparably increased levels of LRRK2 in stabilized and total 
CCV does not exclude different type of interactions of LRRK2 in the two CCV 
pools. These data further provides insight into the complex regulatory mechanism 
for the formation of the stabilized AP2 CCV. In the future, we would like to 
specifically check the activation of the kinase domain of LRRK2, in the stable and 
total CCV and this would provide a better understanding of these regulatory 
mechanisms. 
 
 
 
 
 
 
  85 
 
 
Figure 3.9 (A) Cartoon representing the predicted domain structure of LRRK2; LRRK2 is 
composed of 13 LRRs protein-protein interaction domains, followed by the Roc, a GTPase domain, 
COR domain, a LRRK2 dimerization domain and MAPKKK domain, a kinase domain followed by 
seven WD40 at the C-terminus, which plays a role in protein-protein interaction. Figure adapted 
from (Gandhi et al, 2009) (B) Comparison of the levels and the distribution of LRRK2 in cortices, 
synapses, in the total synaptic CCV (Σ CCV) and in the stabilized CCV (st CCV, blue boxes), from 
wild-type (wt) and σ1B −/− mice. Wild-type level is set to 100% and the numbers below the box-
plot, indicate the number of independent biological samples analyzed. (C) Representative western-
blots of the LRRK2 comparison, shown in B. E. Candiello contributed the Σ CCV data and R. Mishra 
contributed the data from cortex, synapse and the stabilized CCV.  
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Chapter 4: Discussion 
 
 
In our lab, we have generated three AP1 adaptin ‘knockout’ mice models. The 
knockouts of γ1 and μ1A were embryonically lethal and died at the age of 3.5 
day and 13.5 day in-utero respectively (Meyer et al., 2000), (Zizioli et al, 1999). 
Only σ1B-/- mice were viable and fertile, but are hypoactive and have impaired 
motor coordination and also have defects in learning and memory formation 
(Glyvuk et al., 2010). γ1 and μ1A adaptins are ubiquitously expressed, whereas 
σ1B adaptin is an isoform of the ubiquitously expressed σ1A adaptin.  Similarly, 
a mouse knockout of μ1A adaptin isoform, μ1B, expressed in the polarized 
epithelial cells (Ohno et al, 1999), is also viable (Hase et al, 2013). The viability 
and the defects in the σ1B-/- mice, demonstrate that σ1B adaptin is not required 
for the ubiquitous housekeeping functions of AP1, but rather suggests tissue-
specific functions. The brain is the tissue with the highest expression of 
AP1/σ1B complex along with AP1/σ1A, (Glyvuk et al., 2010) thus suggesting 
brain-specific functions of AP1/σ1B adaptin.  
The AP1/σ1B deficient mice are a model for a human severe X-linked mental 
retardation disease (XLMR), in which patients have a premature STOP codon 
in the σ1B gene (Glyvuk et al, 2010; Tarpey et al, 2006).The patients of XLMR 
have severe impaired learning and memory and show a lack of motor 
coordination (Tarpey et al, 2006). 
Since the hippocampus is the site of learning and memory formation, the 
hippocampal synapses from isogenic wild-type and AP1/σ1B -/- mice were 
analyzed in our lab, to study the molecular mechanism of the underlying defects 
in brain functions caused by σ1B deficiency. The studies have demonstrated 
that the AP1/σ1B -/- synapse has slower synaptic vesicle recycling and has 
fewer synaptic vesicles than the wild-type (Glyvuk et al, 2010). The delayed 
synaptic vesicle recycling was accompanied by an accumulation of endosome 
like compartments, and of clathrin-coated vesicles (CCV) (Glyvuk et al, 2010). 
The biochemical characterization of these endosome like compartments 
demonstrated that they are PI3P positive, early endosomes accumulating in the 
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σ1B-/- synapses (Kratzke et al, 2014). Out of all the possible exit routes of 
proteins from the early endosomes, only the multivesicular body (MVB) 
endolysosomal degradative pathway was upregulated (Kratzke et al, 2014). In 
the absence of AP1/σ1B, as in the case of AP1/σ1B-/- synapses, AP1/σ1A 
forms a complex with ArfGAP1-Rabex5 on these early endosomes and up-
regulates the maturation of early endosomes into MVB via the Rab5/Vps34-
pathway (Candiello et al, 2016). 
The accumulated synaptic CCV were isolated on the sucrose gradient and were 
biochemically characterized to understand the molecular mechanism for their 
accumulation.  
 
4.1 Brain-specific AP2 CCV accumulation in the AP1/σ1B-/- synapses  
 
We have isolated the accumulated synaptic CCV on the sucrose density gradient 
and there was no difference in the migration behavior of the CCVs isolated 
from wt, and AP1/σ1B-/- synapses, indicating that the size and the physical 
properties of the CCVs were not significantly altered (Kratzke et al, 2014).  The 
coat compositions of the accumulated CCVs were biochemically characterized 
to understand the molecular mechanism for their accumulation. The 
accumulated CCVs were not crippled AP1/σ1A CCV, as one would expect due 
to one missing adaptin of AP1/σ1B complex, but they were AP2 CCV, 
demonstrating that AP1/σ1B dependent synaptic vesicle recycling is coupled to 
the AP2 mediated endocytosis (Kratzke et al, 2014).  
 
In this study, I have studied the AP2 CCV in more detail to understand the 
mechanism leading to their accumulation in the AP1/σ1B-/- synapses, but first, 
I analyzed whether this altered AP1 and AP2 mediated protein transport is 
synapse specific, or whether it is a general consequence of AP1/σ1B deficiency.  
 
The AP1/σ1B-/- mice also have lipodystrophy with the reduction of adipose 
tissue mass on average by 20% and of epididymal adipose tissue by 50%, 
compared to the wild-type mice (Baltes et al, 2014). This defect is caused by the 
overexpression of Sortilin preventing the degradation of DLK1, an 
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adipogenesis inhibiting factor (Baltes et al, 2014). Sortilin is neurotrophin-
binding receptor also known to form hetero-dimeric receptor complexes. The 
σ1B-/- binding of sortilin is mediated by a specific binding motif on Sortilin, which 
is not bound by σ1A, but the deficiency of σ1B does not completely block the 
transport of Sortilin out of an organelle, rather its transport to the lysosomes is 
reduced (Baltes et al, 2014). The brain is the tissue with the highest expression of 
σ1B as well as Sortilin, but Sortilin and DLK1 level are not upregulated in the brain, 
demonstrating the tissue-specific Golgi network-endosome sorting function of 
AP1/σ1B in the adipocytes (Baltes et al, 2014).  
The AP1/σ1B deficient adipose tissue is the only tissue besides brain, for which 
a σ1B dependent function had been demonstrated (Baltes et al, 2014). Therefore, 
I tested AP1/σ1B-/- adipose tissue for their AP1 and AP2 levels. The AP1/σ1B-
/- adipocytes do not show an increase in AP2 levels, as in the case of AP1/σ1B-
/- hippocampal synapse (Zizioli et al, 2017). Thus, the alterations in the AP1 and 
AP2 dependent protein transport routes are a brain specific phenotype and not 
the general consequence of AP1/σ1B-deficiency.  
 
  89 
4.2. Existence of a sub-pool of stabilized AP2 CCV:   
 
Since, the accumulation of AP2 CCV was a synapse specific phenotype, the 
main goal of this project was to characterize these accumulated AP2 CCV to 
understand the molecular mechanism for their accumulation and their function 
in the AP1/σ1B -/- synapse and thus AP2 functions in wild-type synapses as 
well.  
 
The iTRAQ and semi-quantitative western-blot analyses revealed that the 
accumulated AP2 CCV have altered coat composition, which indicated that 
there could be a sub-population of AP2 CCV accumulating in these synapses. 
We have immunoisolated a sub-pool of AP2 CCV from both wild-type and 
AP1/σ1B-/- synapses, based upon the differential, but stable mode of binding 
of Hsc70 during the uncoating of a CCV. Hsc70 has binding sites on the CCV 
proteins, where it binds more stably and promiscuously, if not guided to the 
disassembly site (Xing et al, 2009; Park et al, 2015; Sousa & Lafer, 2015). Thus, 
we reasoned that if there were a stable pool, it would have a different stable 
mode of binding of Hsc70 and thus, could be immunoisolated with an anti-
Hsc70 monoclonal antibody.  
 
The iTRAQ mass-spectrometry and semi-quantitative western-blot analysis of 
this immunoisolated pool from wild-type and AP1/σ1B-/- synapses 
demonstrates, that the pool of stabilized AP2 CCV is upregulated in the 
AP1/σ1B -/- synapse. The coat composition of these immunoisolated AP2 CCV 
revealed that the levels of Hsc70 bound to them is not increased in the AP1/σ1B 
-/- synapse, despite the increase in its J-domain protein recruiters, Auxilin1 and 
2 (Candiello et al, 2017). Thus, Auxilin 1 and 2 are not able to recruit Hsc70 to 
the disassembly site of the clathrin basket in these CCVs. However, in our 
previous analysis, we have observed a 100% increase in the Hsc70 levels in the 
total CCV pool of AP1/σ1B -/- synapses compared to the wild-type, 
demonstrating that the majority of AP2 CCV in the AP1/σ1B -/- synapses is 
undergoing rapid uncoating similar to the wild-type (Kratzke et al, 2014). The 
immunoisolated pool of the AP2 CCV in the AP1/σ1B-/- synapses also contains 
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an increased amount of clathrin light chain (CLC), which further stabilizes the 
clathrin basket. Thus, the immunoisolated pool of AP2 CCV represents AP2 
CCV with a stabilized clathrin coat and could represent a specialized endocytic 
route in the AP1/σ1B-/- synapses.  
 
4.2.1 Altered active zone dynamics in AP1/σ1B-/- synapses   
 
The stabilized pool of AP2 CCV indeed, represents a novel and specific 
endocytic route in the synapses, as these AP2 CCV are enriched in specific 
cargo proteins. The stabilized AP2 CCV pool in AP1/σ1B-/- synapses is 
enriched in Stonin2, a co-adaptor of AP2 (Candiello et al, 2017). Stonin2 is 
associated with Git1, a scaffolding protein, at the outer rim of the synaptic 
active zone, and they bind to each other. We have observed that Git1 is enriched 
only in the stabilized AP2 CCV pool of the AP1/σ1B-/- synapses, like Stonin2, 
indicating that Stonin2 is transporting Git1 from the active zone in these 
stabilized CCV (Candiello et al, 2017). The stabilized AP2 CCV pool-
transporting Git1 from the active zone appears to prevent its degradation in the 
AP1/σ1B-/- synapses, as the Git1 level is increased in those synapses. 
Deficiency in Git1 impairs synaptic vesicle recycling (Podufall et al, 2014) and 
thus, the increased level of Git1 in these synapses could support the synaptic vesicle 
recycling and could partially compensate for the reduction in synaptic vesicle 
numbers in the AP1/σ1B-/- synapses.  
However, the redistribution of Git1 could also mean that Git1 is not transported 
away from the active zone in the stabilized AP2 CCV, rather it might be retained 
near the active zone until the uncoating of the vesicles. After the uncoating of 
the vesicles, they can fuse back directly with the plasma membrane at the active 
zone and Git1 and Stonin2 could be repositioned at the active zone; or they 
could also lead to the formation of a new active zone. 
 
The natural in-vitro instability of the CCVs and the immunoisolation 
procedures does not allow the precise determination of the ratio of rapid 
uncoating and stabilized AP2 CCV, however, the pool size of the stabilized 
AP2 CCV can be estimated. The increases of AP2 in the total and stabilized 
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pool are almost identical (∼200%) and thus, the pool size of stabilized AP2 
could be estimated by their μ2-Pi ratio (see section 4.2.2 for μ2-Pi, in the 
molecular mechanism for stabilized AP2 CCV formation). The stabilized AP2 
CCV have 215% more of μ2-Pi (Candiello et al, 2017), whereas the total 
synaptic CCV pool has only 30% more μ2-Pi (Kratzke et al, 2014). We can 
assume that the 30% increase in the μ2-Pi in the total synaptic CCV pool is 
mainly due to the stabilized AP2 CCV pool, because total CCV contains less of 
the μ2 phosphorylating AAK1 (Ricotta et al, 2002; Conner et al, 2003), whereas 
the stabilized CCV contain more AAK1. With the given ratio of μ2-Pi between 
total/stabilized pools, 215/30, stabilized CCV represent ∼15%, of the total 
synaptic CCV pool. Such a small size of stabilized CCV specializes in the 
transport of small subsets of specialized active zone proteins, like Stonin2 and 
Git1. AAK1 mediated μ2 phosphorylation has always been discussed exclusively 
for AP2 activation and the initiation of AP2 CCV formation (Ricotta et al, 2002; 
Conner et al, 2003). However, our data shows that AAK1 function is used to 
differentially regulate the AP2 CCV lifetime.  
 
 
4.2.2. Molecular mechanisms for the formation of stabilized AP2 CCV 
 
There are two pools of AP2 CCV accumulated in the AP1/σ1B-/- synapses, one 
is the normal AP2 CCV formed by the canonical Clathrin-mediated-endocytosis 
(CME) pathway and the other formed by specialized molecular pathway leading 
to stabilized and thus longer lived AP2 CCV. We have identified four different 
molecular mechanisms for the formation of the stabilized AP2 CCV. 
 
The first molecular mechanism for the formation of the stabilized AP2 CCV 
is the altered association of the heat shock protein Hsc70, which mediates the 
disassembly of the clathrin basket. Hsc70 is not efficiently recruited to the site 
of clathrin basket disassembly, because the stabilized pool of AP2 CCV has 
only wild-type levels of Hsc70, despite the increased amount of its J-domain 
protein recruiters, Auxilin 1 and 2 (Candiello et al, 2017). It is possible that the 
Hsc70 recruitment to the disassembly site is inhibited by the reduced amount 
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of Hsp110. Hsp110 is a Hsc70 nucleotide exchange factor (NEF), which is 
highly expressed in brain and helps in the dissociation of Hsc70 from the 
clathrin:Hsc70: ADP complex, formed after the disassembly of the clathrin 
basket by Hsc70 (Morgan et al, 2013). The clathrin:Hsc70: ADP complex limits 
the further recruitment of Hsc70 and has to be dissociated by Hsp110. We have 
observed a reduction in the levels of HSP110 in the stabilized AP2 CCV pool 
from AP1/σ1B-/- synapses. The reduction in Hsp110 could be a limiting factor 
for the recruitment of Hsc70. Thus, the reduced amounts of Hsc70 and Hsp110, 
despite the increase in Auxilin1/2 is the first molecular mechanism for the 
stabilization of the stabilized AP2 CCV pool in the AP1/σ1B-/- synapses. 
 
The second molecular mechanism demonstrates that the binding of AP2 to the 
membrane is enhanced in the stabilized AP2 CCV of the AP1/σ1B-/- synapses. 
High-affinity membrane binding of AP2 requires its conformational change 
from a closed into an open conformation, in which the μ2 adaptin cargo binding 
domain comes in close contact of the membrane, enabling its binding to PIP2 
and cargo proteins. This conformational change is mediated by the activity of 
the AAK1 kinase (Ricotta et al, 2002) (Conner et al, 2003). We have observed a 
hyper-phosphorylation of the μ2 in the stabilized AP2 CCV of the AP1/σ1B-/- 
synapses, and also the level of AAK1 kinase is increased in this pool (Candiello 
et al, 2017). Thus, in the stabilized AP2 CCV, AP2 is in the open configuration 
and therefore, bound more stable to the membrane in the stabilized AP2 CCV 
than in the AP2 CCV formed by canonical CME route. This demonstrates the 
second molecular mechanism for the stabilization of those AP2 CCV in 
AP1/σ1B-/- synapses. 
 
The third molecular mechanism is the reduced recruitment of the two 
isoforms of Synaptojanin-1: Synaptojanin-1 ubiquitous and Synaptojanin-1 
brain-specific splice variant. Synaptojanins are the PIP2 phosphatases and their 
activities are required for the release of AP2 from the membrane (McPherson et 
al, 1996). We have observed a dramatic reduction in the levels of both the 
Synaptojanins by 80% in the stabilized AP2 CCV of AP1/σ1B-/- compared to 
the wild-type CCV. This demonstrates that the AP2 is stable bound to the 
membrane in this stabilized pool of AP2 CCV in AP1/σ1B-/- synapses. The 
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reduced level of synaptojanins could either be a consequence of the lower 
amounts of its recruiting proteins, or it could also point towards complex 
regulatory mechanism and the involvements of additional kinases and also 
phosphatases, which could regulate the recruitment of Synaptojanins. 
Therefore, I also investigated the levels of those CCV proteins, known to bind 
Synaptojanin-1. 
 
 
4.2.3 Analysis of Synaptojanin-1 recruiting proteins  
 
In order to understand the drastic reduction of Synaptojanins in the stabilized 
AP2 CCV of AP1/σ1B-/- synapses, we looked for the expression of the proteins, 
which interact directly with Synaptojanin-1, like the BAR domain proteins 
Endophilin A1 and Amphiphysin which are associated with the CCV (Perera et 
al, 2006; Milosevic et al, 2011). The level of Endophilin A1 is not significantly 
altered in the stabilized AP2 CCV of AP1/σ1B-/- synapses (Candiello et al, 
2017), and thus could not explain the reduced recruitment of Synaptojanin-1 to 
this pool. The amphiphysin level is reduced in the stabilized AP2 CCV of 
AP1/σ1B-/- synapses compared to the wild-type, however, the reduction is not 
comparable to the reduction in the levels of synaptojanin-1. Thus, the altered 
levels of curvature sensing BAR domain protein and of the two synaptojanins 
suggest that the two different clathrin-mediated-endocytosis (CME) routes, 
mediated by normal and stabilized pool of AP2 CCV, also differ in their 
budding kinetics. 
 
The fourth molecular mechanism for the formation of stabilized AP2 CCV is 
mediated by Intersectin-1. Besides Endophilin A1 and Amphiphysin, 
Synaptojanins also interacts directly with the CCV protein, Intersectin-1. 
Intersectin 1 (ITSN-1) directly interacts with AP2, Stonin-2 and Dynamin and 
Synaptojanin-1 (Evergren et al, 2007; Pechstein et al, 2010). The levels of AP2, 
Stonin2 and Dynamin is increased in the stabilized AP2 CCV and thus,  one 
would expect the level of Intersectin-1 to be increased as well. We did observe 
a 100% increase in the levels of Intersectin-1 in the total CCV of AP1/σ1B-/- 
synapses compared to the wild-type CCV, in line with the 100% increase in the 
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AP2 levels. However, the levels of Intersectin-1 in the stabilized AP2 CCV of 
AP1/σ1B-/- synapses is reduced, which clearly suggest that Intersectin-1 is 
involved in the differential regulation of synaptic AP2 CCV stability. Thus, the 
reduced level of Intersectin could be one of the reasons for less recruitment of 
Synaptojanins. However, the involvement of kinases become more evident at 
this point, which could explain in detail the reduced levels of Synaptojanins. 
This is the fourth molecular mechanism leading to the formation of the 
stabilized pool of AP2 CCV in the AP1/σ1B-/- synapses. 
 
Intersectin-1 and also Amphiphysin and Endophilin A1 interact with the AP2 
CCV protein, SGIP1 and thus, I also analyzed the levels of this protein in the 
synaptic AP2 CCV. SGIP1 is a F-BAR domain containing protein, homologous 
to FCHo1/2, which senses low curvature membrane and is involved in the early 
stages of CCV budding kinetics (Henne et al, 2010) . I have observed an 
increased level of SGIP1 in the total CCV as well as in the stabilized AP2 CCV 
in the AP1/σ1B-/- synapses. SGIP1 binds to phosphatidylserine and 
phosphoinositides on the plasma membrane and deforms the membrane and also 
speeds up the budding process (Uezu et al, 2007). Thus, SGIP1 is involved in the 
both synaptic CME routes and the CCVs of both the CME routes are formed at the 
same speed. However, SGIP1 appears not to be involved in the differential 
regulation of the two CME pathways.  
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4.3 Regulation of stabilized AP2 CCV formation in AP1/σ1B-/- 
synapses:  
 
Alterations in the levels of CCV coat proteins alone do not explain the reduced 
amounts of some of them in the stabilized AP2 CCV pool of AP1/σ1B-/- 
synapses. Thus, the alterations appear not to be simply due to the stoichiometric 
alterations, rather it points towards altered regulatory mechanisms and the 
involvement of kinases and phosphatases.  
One kinase known to be associated with CCV is LRRK2 kinase. Mutations in 
the LRRK2 kinase are associated with Parkinson’s disease (Paisán-Ruı́z et al, 
2004). LRRK2 is a large, multi-domain protein, which interacts with many 
different proteins and is involved in numerous protein trafficking pathways 
including synaptic vesicle endocytosis (Arranz et al, 2015; Paisán-Ruıź et al, 
2004; Pan et al, 2017; Matta et al, 2012).  
 
We determined a reduction in synapse LRRK2 level in AP1/σ1B-/- synapses. 
However, its reduced level does not limit its recruitment in the total as well as 
in the stabilized AP2 CCV pools. The comparable increase in the levels of 
LRRK2 in both, the total and stabilized AP2 CCV pool in the AP1/σ1B-/- synapses 
does not necessarily mean that LRRK2 is not involved in the differential 
regulation of the two CME pathways. LRRK2 is a multi-domain protein with a 
number of protein interaction domains, and it is possible that in the total CCV 
and in the stabilized CCV, LRRK2 undergoes different kind of protein 
interactions, leading to different effects on CCV stability. Proteins, which 
directly activate the kinase domain of LRRK2, are candidates to investigate in 
total and stabilized AP2 CCV in AP1/σ1B-/- synapses in the future, to 
understand the differential regulation of stabilized AP2 CCV formation.  
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Figure 4.1 Cartoon summarizing the differences between wild-type (left) and σ1B-/- (right) 
synapses. The function of different type of CCVs formed and the alterations in the active zone 
dynamics in the σ1B-/- synapses has been depicted. These data are published, hence the figure 
is adapted from (Candiello et al, 2017). 
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Summary 
 
 
The knockout mouse model of AP1/σ1B adaptin generated in our lab shows 
hypoactivity and severe neurological defects. Figure 4.1, summarizes the 
differences between wild-type and AP1/σ1B-/- synapses. The analysis of 
hippocampal synapses had revealed that AP1/σ1B-/- have slower synaptic 
vesicle recycling and fewer synaptic vesicles, but an accumulation of early 
endosomes and of AP2 CCV (Glyvuk et al, 2010; Kratzke et al, 2014). In 
addition, AP1/σ1B-/- have an upregulated multi-vesicular body (MVB) 
endolysosomal degradative pathway, possibly degrading about one-third of 
synaptic vesicle proteins (Kratzke et al, 2014; Candiello et al, 2016).  
 
In this work, we have analyzed synaptic AP2 CCV in more detail to understand the 
molecular mechanisms leading to the formation of stabilized, and thus long-lived 
AP2 CCV, as well as the functions of these CCV in synaptic plasticity. The 
biochemical characterization of the wild-type and AP1/σ1B-/- synapses 
demonstrates, that there are two different pools of AP2 CCV accumulated in the 
AP1/σ1B-/- synapses: one is the normal AP2 CCV pool formed by canonical 
clathrin-mediated endocytosis (CME) pathway and another one of stabilized AP2 
CCV formed by a specific CME pathway. The stabilized AP2 CCV mediate the 
sorting and transport of Stonin2 and Git1, two synaptic active zone proteins, leading 
to alterations in the active zone dynamics of AP1/σ1B-/- synapses. Canonical CME 
is upregulated in these synapses, for yet unknown reasons. 
 
We have identified four different molecular mechanisms, which lead to the 
formation of the stabilized AP2 CCV in the AP1/σ1B-/- synapses:  
 Reduced recruitment of CCV uncoating proteins, Hsc70 and its 
nucleotide exchange factor (NEF), Hsp110 
 Enhanced stability of AP2 membrane binding by μ2 hyper-
phosphorylation and thus AP2 hyper-activation by increased AAK1 
kinase levels and by the- 
 Reduced recruitment of PIP2 phosphatase, Synaptojanin-1. 
 Reduced recruitment of Intersectin-1. 
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This study raises several questions, which need to be addressed in the future. 
What are the regulatory mechanisms leading to altered coat protein recruitment 
in the stabilized AP2 CCV pool in AP1/σ1B-/- synapses? How does the Git1 
and Stonin2 sorting affects the molecular architecture and function of the active 
zone? Are there new active zones formed in the AP1/σ1B-/- synapses due to the 
increased CME of active zone scaffolding proteins? How are the altered active 
zone dynamics observed in the AP1/σ1B-/- synapses linked to the synaptic 
signaling? These are some of the important questions, our lab will be focusing 
on in the future. 
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